US20160151177A1 - Stent with Outer Member to Embolize an Aneurysm - Google Patents
Stent with Outer Member to Embolize an Aneurysm Download PDFInfo
- Publication number
- US20160151177A1 US20160151177A1 US14/562,725 US201414562725A US2016151177A1 US 20160151177 A1 US20160151177 A1 US 20160151177A1 US 201414562725 A US201414562725 A US 201414562725A US 2016151177 A1 US2016151177 A1 US 2016151177A1
- Authority
- US
- United States
- Prior art keywords
- aneurysm
- stent
- inner structure
- flexible layer
- outer flexible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00898—Material properties expandable upon contact with fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/823—Stents, different from stent-grafts, adapted to cover an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0065—Additional features; Implant or prostheses properties not otherwise provided for telescopic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Definitions
- This invention relates to devices to treat aneurysms.
- An aneurysm is an abnormal bulging or ballooning of a blood vessel. Rupture of brain aneurysms can cause stroke, death, or disability. Around one-third of people who have a brain aneurysm that ruptures will die within 30 days of the rupture. Of the survivors, around half of them suffer some permanent loss of brain function. Many aneurysms are not identified until they rupture. However, identification of intact aneurysms is increasing due to increased outpatient imaging. Ruptured aneurysms must be treated to stop the bleeding or to prevent re-bleeding. Intact aneurysms may or may not be treated to prevent rupture, depending on their characteristics. Wide neck aneurysms are less prone to rupture, but are harder to treat. In the U.S., it has been estimated that over 10 million people have brain aneurysms and 30,000 people each year have a brain aneurysm that ruptures.
- Clipping is the application of a small clip to the aneurysm neck from outside the vessel to seal off the aneurysm. For most brain aneurysms, this involves invasive surgery including removing a section of the skull. Clipping began in the 1930's and is well-established. Clipping is more common in the U.S. than in Europe. Around half of all aneurysms are treated by clipping. There are many aneurysm clips in the prior art. However, due to its invasive nature, clipping is decreasing. Potential disadvantages of clipping can include: significant health risks associated with major surgery of this type; and long recovery times, even when the surgery itself goes well.
- Metal coiling is the endovascular insertion of metal coils into the aneurysm to reduce blood flow and promote embolization in the aneurysm. Historically, metal coils have been platinum. Coils are more common in Europe than in the U.S. There are many examples of metal coils.
- metal coils can include: low percentage of aneurysm volume filled (low occlusion is associated with a higher risk of rupture); compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty later clipping aneurysms filled with metal coils, if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
- Combination Metal/Textile/Foam/Gel Coils Coils with a combination of metal and other materials can be used to try to achieve greater occlusion volume than metal coils alone. These other materials include textile, foam, and gel elements. Textile strands can be woven into the coils to add bulk. Coils can be covered with soft foam. Gel elements can be strung together into elongated structures. Examples of related art that appear to use this approach includes the following: U.S. Pat. Nos.
- Patent Applications 20040158282 Jones, Donald et al.), 20050267510 (Razack, Nasser), and 20060058834 (Do, Hiep et al.).
- Potential disadvantages of combination coils can include: remaining gaps between loops; compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty clipping aneurysms filled with coils with metal components later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils.
- Inflatable Balloons Approximately two decades ago, there were numerous efforts to treat aneurysms by permanently filling them with inflatable balloons. These efforts were largely abandoned due to the risks of balloon deflation, prolapse into the parent vessel, aneurysm rupture, and recanalization. There are, however, examples of relatively recent art that appear to use inflatable balloons to treat aneurysms: U.S. Pat. Nos. 6,569,190 (Whalen et al.) and 7,083,643 (Whalen et al.), and U.S.
- Patent Applications 20030135264 (Whalen et al.), 20030187473 (Berenstein, Alejandro et al.), 20060292206 (Kim, Steven et al.), 20070050008 (Kim, Steven et al.), and 20070055355 (Kim, Steven et al.).
- Potential disadvantages of using inflatable balloons to permanently fill aneurysms can include: balloon deflation; prolapse of the balloon into the parent vessel; aneurysm rupture due to balloon pressure; and recanalization.
- a mesh structure generally metal, that can be expanded or contracted by human-controlled mechanical motion so as to block the aneurysm neck and/or to fill the main volume of the aneurysm.
- a wire structure can be inserted through the aneurysm neck in a narrow configuration and then transformed into an “hour-glass” shape that collapses to block the aneurysm neck when activated by a human controller. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
- Patent Applications 20020042628 Choin, Yem et al.), 20020169473 (Sepetka, Ivan et al.), 20030083676 (Wallace, Michael), 20030181927 (Wallace, Michael), 20040181253 (Sepetka, Ivan et al.), 20050021077 (Chin et al.), 20060155323 (Porter, Stephen et al.), 20070088387 (Eskridge, Joseph et al.), 20070106311 (Wallace, Michael et al.), and 20080147100 (Wallace, Michael).
- Self-Expanding Standard-Shape Occluders Another approach to treating aneurysms uses standard-shaped structures that self-expand when released into the aneurysm.
- the structure may be a mesh of “shape memory” metal that automatically expands to a standard shape when released from the confines of the catheter walls.
- the structure may be a gel that expands to a standard shape when exposed to moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
- Patent Applications 20030093097 (Avellanet, Ernesto et al.), 20030195553 (Wallace, Michael et al.), 20050033349 (Jones, Donald et al.), 20060052816 (Bates, Brian et al.), and 20060235464 (Avellanet, Ernesto et al.) and WIPO Patents WO/2006/084077 (Porter, Stephen et al.) and WO/1996/018343 (McGurk et. al.).
- Such self-expanding standard-shape structures can include: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
- Self-Expanding Custom-Modeled Occluders A variation on self-expanding standard-shape occluders (discussed above) are self-expanding occluders that are custom modeled before insertion so as to fit the shape of a particular aneurysm. As an example sequence—the aneurysm can be imaged, the image is used to custom model the occluding structure, the occluding structure is compressed into a catheter, the occluding structure is inserted into the aneurysm, and the occluding structure then self-expands to fill the aneurysm.
- the occluding structure may be made from a gel that expands upon contact with moisture.
- Potential disadvantages of self-expanding custom-modeled occluders can include: the complexity and expense of imaging and modeling irregularly-shaped aneurysms; difficulty compressing larger-size structures into a catheter; difficulty inserting the occluding structure in precisely the correct position; and difficulty getting a gelatinous surface to anchor solidly to aneurysm walls.
- Congealing Liquid or Gel Another approach to treating aneurysms involves filling an aneurysm with a liquid or gel that congeals rapidly. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,569,190 (Whalen et al.), 6,626,928 (Raymond et al.), 6,958,061 (Truckai et al.), and 7,083,643 (Whalen et al.), and U.S. Patent Application 20030135264 (Whalen et al.).
- a congealing liquid or gel can include: leakage of the congealing substance into the parent vessel, potentially causing a stroke; difficulty filling the entire aneurysm if the substance begins to congeal before the aneurysm is full; and seepage of toxic substances into the blood stream.
- Biological and/or pharmaceutical agents can enhance the performance of a variety of mechanical treatment methods for aneurysms. For example, they can speed up the natural embolization process to occlude the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Patent Applications 20060206139 (Tekulve, Kurt J.), 20070168011 (LaDuca, Robert et al.), and 20080033341 (Grad, Ygael).
- U.S. Patent Applications 20060206139 Tekulve, Kurt J.
- 20070168011 LaDuca, Robert et al.
- 20080033341 Grad, Ygael
- biological and/or pharmaceutical approaches are not sufficient as stand alone treatment approaches for many cases. Accordingly, they share most of the potential disadvantages of the baseline approach to which the biological or pharmaceutical agents are added.
- Embolic-Emitting Expanding Members Another approach involves an expanding member within the aneurysm that emits embolic elements into the aneurysm.
- expanding members include bags, meshes, and nets.
- embolic elements include coils and congealing liquids. This can be viewed as another way to block the aneurysm neck while delivering embolics into the volume of the aneurysm.
- the distal portion of an expanding bag may leak embolic elements into the aneurysm, but the proximal portion of the expanding member does not leak embolics into the parent vessel. Examples of related art that appear to use this approach include the following: U.S. Pat. No.
- Shape Memory Structures inside Expanding Members A variation on the shape memory approach above involves the addition of an expanding member around the shape memory structure. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,861,003 (Latson et al.), 6,346,117 (Greenhalgh), 6,350,270 (Roue), 6,391,037 (Greenhalgh), and 6,855,153 (Saadat).
- Standard (High-Porosity) Stent A stent is a structure that is inserted into a vessel in a collapsed form and then expanded into contact with the vessel walls. Standard stents are generally highly porous, metal, and cylindrical. A high-porosity stent allows blood to flow through the stent walls if there are any branching or secondary vessels in the vessel walls. Blood flow through a stent wall into a branching or secondary vessel is desirable, but blood flow through a stent wall into an aneurysm is not. Accordingly, a high-porosity stent in the parent vessel is not a good stand-alone aneurysm treatment. A high-porosity stent in the parent vessel can, however, help to keep coils or other embolic members from escaping out of the aneurysm into the parent vessel.
- a high-porosity stent in the parent vessel in combination with coils in the aneurysm still leaves the following disadvantages of using coils alone: low percentage of aneurysm volume filled (and low occlusion is associated with a higher risk of rupture); compaction of coils over time; significant risk of recanalization; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
- Uniformly Low-Porosity Stent Another approach involves inserting a uniformly low-porosity stent into the parent vessel.
- the low-porosity stent blocks the flow of blood through the stent walls into the aneurysm, causing beneficial embolization of the aneurysm.
- the stent may have one or more layers that are impermeable to the flow of liquid.
- this approach can be used as a stand-alone aneurysm treatment. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
- Patent Application 20080319521 (Norris et al., 2008). Potential disadvantages of this approach can include: undesirably blocking blood flow to branching or secondary vessels that are close to the aneurysm and are covered by the stent wall; difficulty achieving a snug fit across the neck of the aneurysm if the parent vessel is curved, twisted, or forked; and poor attachment of the stent with the parent vessel wall due to the impermeable nature of the stent wall.
- Uniformly Intermediate-Porosity Metal Stent This approach pursues creation of a stent with a uniform intermediate porosity that provides a compromise between the benefits of a high-porosity stent in the parent vessel (good blood flow to nearby branching or secondary vessels) and the benefits of a low-porosity stents in the parent vessel (blocking blood flow to the aneurysm).
- Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,770,087 (Layne et al., 2004), 7,052,513 (Thompson, 2006), and 7,306,624 (Yodfat et al., 2007), and U.S.
- Patent Applications 20070207186 (Scanlon et al.,2007), 20070219619 (Dieck et al., 2007), 20070276470 (Tenne, 2007), 20070276469 (Tenne, 2007), and 20080039933 (Yodfat et al., 2008).
- the main potential disadvantage of this approach is that it may perform neither function very well. It may unreasonably block flow to a branching or secondary vessels (causing a stroke) and may inadequately block blood flow to the aneurysm (leaving it vulnerable to rupture).
- Pre-Formed Differential Porosity Stent This approach involves creating a stent with different levels of porosity for different wall areas, before the stent is inserted into the parent vessel. The goal is two-fold: (1) to place wall areas with high porosity over openings to branching or secondary vessels; and (2) to place wall areas with low porosity over the neck of the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
- Potential disadvantages of this approach include: difficulty injecting the embolizing substance through the stent wall without having it leak back into the parent vessel; leakage of embolizing liquid or gel between the stent and the parent vessel into the blood stream, where it blocks a downstream vessel and causes a stroke; challenges containing the embolic material within curving vessels or vessels with irregular walls; and difficulty using this method to fill narrow-neck aneurysms.
- Post-Implantation Surface Modification This approach creates different degrees of porosity in different wall areas after the stent is implanted. The goal is to decrease the porosity of the stent wall in the area of the aneurysm neck, but to leave the rest of the stent wall relatively porous to allow blood flow to branching or secondary members. Also, high porosity in other areas of the stent wall aids in the attachment and integration of the stent to the parent vessel.
- this approach does not fill the gap between the stent wall and the parent vessel wall with some type of solidifying liquid, but rather modifies the wall of the stent itself This reduces the risk of embolic liquid or members leaking out between the stent and the parent vessel wall into the blood stream.
- This invention can be embodied in a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm.
- the stent wall includes an inner structure, such as an expandable metal mesh, that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer, such as a flexible fabric net, that covers all or part of the inner structure.
- Embolic members are placed and retained in the gap between the inner structure and the outer layer in the area of the aneurysm neck in order to reduce blood flow to the aneurysm.
- This invention can also be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage less than the first percentage.
- FIGS. 1 through 24 show possible embodiments of this stent, but do not limit the full generalizability of the claims.
- FIG. 1 shows an opaque side view of one embodiment of this stent after it has been inserted and expanded within the parent blood vessel of an aneurysm.
- FIG. 2 shows an alternative view of this same embodiment, with the two layers of the stent being transparent in order to allow a clearer view of the guidewires.
- FIG. 3 shows an opaque side view of this same embodiment, except that a catheter to deliver embolic members has now been slid along the guidewires to reach an opening in the inner mesh structure.
- FIG. 4 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members.
- FIG. 5 shows an opaque side view of this same embodiment, except that a plurality of embolic members have now been inserted into the gap between the inner mesh structure and the outer flexible layer in the area of the aneurysm neck.
- FIG. 6 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members.
- FIGS. 7 and 8 show this same embodiment after the detachment and withdrawal of the guidewires and catheter.
- FIG. 9 shows a close-up view of guidewires attached to the inside surface of a hexagonal opening in the inner mesh structure.
- FIG. 10 shows a close-up view of the distal end of the catheter as it slides along the guidewires toward the inner mesh structure.
- FIG. 11 shows a close-up view of the distal end of the catheter after it has completely slid along the guidewires to reach the inner mesh structure and be aligned with an opening in this inner mesh structure.
- FIG. 12 shows a close-up view of embolic members being propelled through the catheter by a flow of sterile saline solution.
- FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure and the outer flexible layer, with both guidewires and catheter having been withdrawn.
- FIGS. 14 and 15 show examples of this stent with a high-flexibility area of the outer flexible layer that is identified by radioopaque lines and that is positioned to cover the aneurysm neck.
- FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs.
- FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs.
- FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections.
- FIGS. 1 through 24 show possible embodiments of this stent. However, these embodiments are not exhaustive. These figures do not limit the full generalizability of the claims.
- FIG. 1 shows an opaque side view of one embodiment of this stent, after it has been inserted and expanded within the parent blood vessel of an aneurysm.
- FIG. 1 also shows a cross-sectional side view of the parent blood vessel 103 with aneurysm 101 including aneurysm neck 102 .
- the stent system has a resilient inner structure 104 , which is a metal mesh with a hexagonal pattern, and an outer flexible layer 105 that is configured like a net around the inner structure.
- FIG. 1 also shows two guidewires 106 that are attached to inner structure 104 .
- the stent is shown in FIG. 1 in an already inserted and expanded configuration. Many methods of stent insertion and expansion, such as by catheter and balloon, are well known in the art and the precise methods of insertion and expansion are not central to this invention.
- the wall of the stent consists of two layers.
- the inner layer of the stent wall is an expandable and resilient metal mesh structure 104 with a hexagonal pattern. Many other types of expandable mesh structures may also be used.
- this inner mesh structure may be made from stainless steel, a nickel-titanium alloy, cobalt chromium or a cobalt-chromium alloy, titanium or a titanium alloy, tantalum or a tantalum allow, or polymeric-based resin or another polymer.
- the outer layer of the stent is a flexible fabric net 105 .
- the outer flexible layer may be made from latex, nylon, polyester, teflon, silicone, HDPE, polycarbonate urethane, polyether-polyamide copolymer, polyethylene terephthalate, polyolefin, polypropylene, polytetrafluorethylene, polytetrafluoroethene, polyurethane, or polyvinyl chloride.
- the inner mesh structure and the outer flexible layer there is a gap between the inner mesh structure and the outer flexible layer and these layers are not connected to each other. In other examples of this invention, there may be no gap between these layers until embolic members are inserted between them in the area of the aneurysm neck.
- the two layers may be connected at multiple points or seams in order to form separate pouches between the layers for more precise localized containment of the embolic members between the layers.
- the wall may be comprised of more than two layers.
- FIG. 2 shows an alternative view of the same embodiment of this stent that is shown in FIG. 1 .
- FIG. 2 is the same as FIG. 1 except that FIG. 2 shows the two layers of the stent as transparent in order to allow a clearer view of two guidewires 106 that are attached to the inner mesh structure of the stent wall.
- these two guidewires 106 were attached to the inner structure of the stent at a specific point before insertion of the stent and the operator has aligned this point with the aneurysm neck 102 during stent placement within the parent vessel 103 .
- these two guidewires 106 will be used to guide a catheter that delivers embolic members into the gap between the inner wall structure 104 and the outer flexible layer 105 .
- guidewires need not be used; the catheter may be directed to the inner wall structure using real-time imaging and attached to the inner wall structure with a grasping or hooking mechanism.
- FIG. 3 shows an opaque side view of the same embodiment of this stent that is shown in FIG. 1 , except that a catheter 301 to deliver embolic members (including embolic member 302 ) has been slid along guidewires 106 to reach an opening in the inner mesh structure 104 .
- embolic members including 302
- sterile embolic members are propelled by a flow of sterile saline solution through catheter 301 for insertion into the gap between inner mesh structure 104 and outer flexible layer 105 .
- the saline solution propels the embolic members through the catheter and into the gap, wherein the members expand and are trapped within the gap.
- the saline solution escapes through the openings in the mesh.
- other means may be used to transport the embolic members along the catheter, such as miniature conveyor belts or rotating helix mechanisms.
- the embolic members are compressible micro-sponges that expand upon ejection from the catheter.
- these micro-sponges may be made from cellulose, collagen, acetate, alginic acid, carboxy methyl cellulose, chitin, collagen glycosaminoglycan, divinylbenzene, ethylene glycol, ethylene glycol dimethylmathacrylate, ethylene vinyl acetate, hyaluronic acid, hydrocarbon polymer, hydroxyethylmethacrylate, methlymethacrylate, polyacrylic acid, polyamides, polyesters, polyolefins, polysaccharides, polyurethane, polyvinyl alcohol, silicone, urethane, and vinyl stearate.
- the embolic members may be gels, beads, or coils.
- the embolic members (such as 302 ) are retained with the gap between the inner mesh structure 104 and outer flexible layer 105 because they expand upon ejection from the catheter 301 and can not exit the same opening in the inner mesh structure by which they entered this gap.
- the embolic members need not expand, but the opening by which they enter the gap may be closed when the catheter is removed to trap them within the gap.
- FIG. 4 shows an alternative view of the same embodiment of this stent that is shown in FIG. 3 , except that the two layers of the stent are transparent in order to allow a clearer view of catheter 301 and embolic members (including 302 ).
- FIG. 5 shows an opaque side view of the same embodiment of this stent that is shown in FIG. 3 , except that a plurality of embolic members (including 302 ) have now been delivered via catheter 301 and inserted into the gap between the inner mesh structure 104 and the outer flexible layer 105 in the area of the aneurysm neck.
- the flexibility of outer layer 105 allows it to distend into the aneurysm neck to more thoroughly block blood flow through the neck.
- a sufficient volume of embolic members has been inserted into this gap in the area of the aneurysm neck to occlude the flow of blood into aneurysm 101 , thereby promoting embolization of the aneurysm.
- FIG. 6 shows an alternative view of the same embodiment of this stent that is shown in FIG. 5 , except that the two layers of the stent are transparent in order to allow a clearer view of catheter 301 and embolic members (including 302 ).
- FIGS. 7 and 8 show the same embodiment, but after the detachment and withdrawal of the guidewires 106 and catheter 301 .
- the guidewires may be detached from the inner mesh structure by application of a mild electric current and the catheter may be removed by simple mechanical withdrawal.
- Many other methods for detaching and removing guidewires and catheters are known in the prior art and the exact detachment and removal mechanisms are not central to this invention.
- Blood flow through the aneurysm neck is now largely blocked to promote embolization of the aneurysm, but other areas of the stent remain largely porous to foster integration with the walls of the parent vessel and to allow blood flow to any secondary vessels that may branch off from the parent vessel along the length of the stent.
- FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall.
- FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall.
- FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall.
- only small square patches of inner mesh structure 104 and outer flexible layer 105 are shown (indicated by dashed line borders); and the size of the gap between these two layers is exaggerated to provide a clearer view of how embolic members are inserted within this gap.
- guidewires 106 are attached to inner mesh structure 104 before the stent is inserted in the parent vessel and catheter 301 is guided to the inner mesh structure 104 by means of
- FIG. 9 shows a close-up view of guidewires 106 attached to the inside surface of a hexagonal opening in inner mesh structure 104 .
- FIG. 9 also shows outer flexible layer 105 .
- FIG. 9 corresponds to a close-up view of a small area of FIGS. 1 and 2 , the area in which guidewires 106 are attached to inner mesh structure 104 .
- FIG. 10 shows a close-up view of the distal end 1001 of catheter 301 as it slides along guidewires 106 toward inner mesh structure 104 . The other (proximal) end of catheter 301 remains outside the person's body.
- FIG. 11 shows a close-up view of the distal end 1001 of catheter 301 after it has completely slid along guidewires 106 to reach inner mesh structure 104 and be aligned with one hexagonal opening of this structure.
- FIG. 12 shows a close-up view of embolic members (including 302 ) being propelled through catheter 301 by a flow of sterile saline solution.
- the embolic members are micro-sponges that expand upon ejection from the catheter into the gap between the inner mesh structure 104 and outer flexible layer 105 .
- FIG. 12 corresponds to a close-up view of a small area of FIGS. 3 and 4 , the area in which the guidewires 106 are attached to the inner mesh structure 104 .
- FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure 104 and outer flexible layer 105 . Also, guidewires 106 and catheter 301 have been detached and withdrawn. FIG. 13 corresponds to a close-up view of a small area of FIGS. 7 and 8 , the area in which the guidewires were attached to the inner mesh structure.
- FIGS. 14 and 15 show an opaque side view of two examples of this stent that feature an outer flexible layer with differential flexibility. Having a stent with one area of the outer flexible layer that has greater flexibility and placing this area over the aneurysm neck has two advantages. First, it facilitates insertion of a substantial mass of embolic members into the gap between the inner mesh and the outer flexible layer in the area of the aneurysm neck in order to thoroughly occlude the aneurysm neck. Second, although the walls of the parent vessel resist migration of embolic members through the gap away from the aneurysm neck area, having less flexibility of the outer layer outside the aneurysm neck area provides additional resistance to possible migration of embolic members.
- FIGS. 14 and 15 show a stent, with an inner structural mesh 104 and an outer flexible net 105 , having been inserted into parent vessel 103 of aneurysm 101 with aneurysm neck 102 .
- FIGS. 14 and 15 also show a saddle-shaped area 1401 of the outer flexible net that has greater flexibility than the rest of the net. This saddle-shaped area with greater flexibility is positioned to cover the aneurysm neck when the stent is placed and expanded.
- the stent also features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion of the stent.
- the saddle-shaped area 1401 is identified for the operator by radioopaque longitudinal lines (including 1402 ) and lateral circumferential lines (including 1403 ) that intersect the outer boundaries of the saddle-shaped area.
- the operator positions the stent so that the aneurysm neck is centered, in each direction, between these radioopaque lines.
- the saddle-shaped area 1401 is identified by radioopaque longitudinal line 1501 and lateral circumferential line 1502 that intersect the center of the saddle-shaped area.
- the operator positions the stent so that the intersection of these lines is centered within the aneurysm neck.
- the radioopaque lines are lateral circumferential and longitudinal lines. In other examples, the radioopaque lines may trace the exact perimeter of the higher-flexibility area.
- a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm” (Nov. 18, 2009 specification, page 10, lines 23-25); “stent wall includes an inner structure . . . that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer . . . that covers . . . part of the inner structure” (Nov. 18, 2009 specification, page 10, lines 25-27); “one area of the outer flexible net . . .
- the area may span a higher or lower percentage of the surface area of the stent” (Nov. 18, 2009 specification, page 17, line 28-page 18, line 1); “features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion ” (Nov. 18, 2009 specification, page 17, lines 17-19); “layers may be connected at multiple points or seams” (Nov. 18, 2009 specification, page 13, lines 30-31); and “In this embodiment . . . these layers are not connected to each other” (Nov. 18, 2009 specification, page 13, lines 27-28).
- an invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein this outer flexible layer spans a first percentage of the surface area of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the surface area of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage.
- the outer flexible layer can be less porous than the inner structure.
- this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
- this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein the inner structure and outer flexible layer are connected to each other at multiple points or seams, and wherein one or more of these multiple points or seams are disconnected during expansion of the inner structure.
- the outer flexible layer can be less porous than the inner structure.
- this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
- FIGS. 16 through 24 show three examples of how this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that spans a first percentage of the circumference of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the circumference of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage.
- FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs.
- FIG. 16 shows a longitudinal cross-sectional view of aneurysm 1601 and a longitudinal cross-sectional view of the parent vessel of the aneurysm.
- FIG. 16 also shows a longitudinal side view of a device that has been inserted into the parent vessel of aneurysm 1601 .
- FIG. 16 shows this device after the device has been placed within the parent vessel and after an outer flexible layer ( 1604 ) has been aligned with the neck of the aneurysm, but before an inner structure ( 1602 ) has been expanded.
- this device comprises: inner structure ( 1602 ) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer ( 1604 ) that spans part of inner structure 1602 ; multiple points or seams (including 1605 and 1606 ) by which outer flexible layer 1604 is connected to inner structure 1602 ; multiple arcuate ribs or tracks 1607 to which the multiple points or seams (including 1605 and 1606 ) are attached; and inflatable member 1603 which is used to expand inner structure 1602 .
- inner structure 1602 is an expandable resilient tubular mesh.
- outer flexible layer 1604 is a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602 .
- outer flexible layer 1604 can have smaller surface pores or openings (as shown in FIGS. 9 through 13 ) and/or be less permeable to blood than inner structure 1602 .
- outer flexible layer 1604 can be impermeable to blood.
- outer flexible layer 1604 can have shapes other than a saddle shape.
- outer flexible layer 1604 can have a semi-tubular shape.
- outer flexible layer 1604 spans a first percentage of the circumference of inner structure 1602 before expansion of inner structure 1602 . In this example, outer flexible layer 1604 spans (a maximum of) approximately 75% of the circumference of inner structure 1602 before expansion of inner structure 1602 . In other examples, an outer flexible layer can span a pre-expansion percentage of the circumference of the inner structure in the range of 50% to 100%.
- arcuate ribs or tracks can encircle the entire circumference of inner structure 1602 .
- arcuate ribs or tracks can partially encircle a portion of the circumference of inner structure 1602 .
- arcuate ribs or tracks can fully or partially encircle the circumference of inner structure 1602 in a plane which is substantially perpendicular to the longitudinal axis of inner structure 1602 .
- arcuate ribs or tracks (such as 1607 ) can expand or telescope longer when inner structure 1602 expands.
- inflatable member 1603 can be a balloon. In an example, inflatable member 1603 can be inflated by filling it with a liquid, such as saline or contrast media. In an example, inflatable member 1603 can be inflated by filling it with a gas, such as carbon dioxide. In an example, this device can further comprise imaging-detectable markings (as shown in FIGS. 14 and 15 ) to help an operator align outer flexible layer 1604 with the neck of the aneurysm. In an example, this device can further comprise radioopaque markings to help an operator align outer flexible layer 1604 with the neck of the aneurysm.
- this device can further comprise ultrasound-detectable markings to help an operator align outer flexible layer 1604 with the neck of the aneurysm.
- three-dimensional ultrasound imaging can be used to guide placement of the device and/or to align the outer layer 1604 with the neck of the aneurysm.
- FIG. 16 shows this device before inner structure 1602 is expanded by expansion of inflatable member 1603 .
- FIG. 17 shows this same device after inner structure 1602 has been expanded by expansion of inflatable member 1603 .
- the (maximum) percentage of the surface area of inner structure 1602 which is spanned by outer flexible layer 1604 is smaller after expansion of inner structure 1602 . This is because outer flexible layer 1604 has been expanded less, or not at all, during the expansion of inner structure 1602 .
- the (maximum) percentage of the circumference of inner structure 1602 which is spanned by outer flexible layer 1604 is smaller after the expansion of inner structure 1602 .
- outer flexible layer 1604 has been expanded less, or not at all, during the expansion of inner structure 1602 .
- the post-expansion percentage of the circumference of inner structure 1602 which is spanned by outer flexible layer 1604 is approximately 30%. In an example, this percentage can be in the range of 20% to 60%
- outer flexible layer 1604 spans a first (pre-expansion) percentage of the circumference of inner structure 1602 before inner structure 1602 is expanded, spans a second (post-expansion) percentage of the circumference of inner structure 1602 after inner structure is expanded, and the first percentage is larger than the second percentage. This is because the surface area of the outer flexible layer 1604 expands less (or not at all) relative to the expansion of inner structure 1602 .
- This differential expansion of outer flexible layer 1604 vs. inner structure 1602 creates a region of low-porosity over the aneurysm neck. This advantageously helps to block blood flow through the aneurysm without deleteriously blocking blood flow to nearby branching blood vessels (such as the small branching vessel shown on side of the parent vessel which is opposite the aneurysm neck).
- outer flexible layer 1604 has less expansion (or none at all) compared to the expansion of inner structure 1602 because outer flexible layer 1604 is connected to inner structure 1602 by means of multiple points or seams (such as 1605 and 1606 ) which are able to slide along multiple arcuate ribs or tracks (such as 1607 ) along the circumference of inner structure 1602 .
- outer flexible layer 1604 does not expand.
- outer flexible layer 1604 slides on the arcuate ribs or tracks via multiple points or seams (including 1606 ). This is why, in this example, outer flexible layer 1604 (which does not expand) covers a smaller percentage of the surface area of inner structure 1602 (which does expand) after inner structure 1602 has been expanded.
- inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move along the circumference of the inner structure during expansion of the inner structure.
- inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move on a track along the circumference of the inner structure during expansion of the inner structure.
- a first subset (including 1606 ) of the multiple points or seams can slide along arcuate ribs or tracks (such as 1607 ) when inner structure 1602 expands, but a second subset (including 1605 ) of the multiple points or seams does not slide. Having a first subset (including 1606 ) of multiple points or seams slide allows outer flexible layer 1604 to not expand when inner structure 1602 expands. Having a second subset (including 1605 ) of multiple points or seams which do not slide helps to keep outer flexible layer 1604 properly positioned over the aneurysm neck during expansion of inner structure 1602 .
- FIG. 18 shows the same device that was shown in FIGS. 16 and 17 , but in a final configuration after inflatable member 1603 has been removed.
- FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs.
- FIG. 19 shows this device before inner structure ( 1602 ) has been expanded.
- the device shown in FIG. 19 comprises: inner structure ( 1602 ) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer ( 1604 ) that spans part of inner structure 1602 ; multiple arcuate ribs (including 1901 ) outside outer flexible layer 1604 ; and inflatable member 1603 which is used to expand inner structure 1602 .
- inner structure 1602 is an expandable resilient tubular mesh.
- outer flexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602 .
- FIG. 19 shows this device before inner structure 1602 is expanded.
- FIG. 20 shows this device after inner structure 1602 has been expanded.
- FIG. 21 shows this device in a final configuration after inflatable member 1603 has been removed.
- arcuate ribs are outside outer flexible layer 1604 .
- arcuate ribs (such as 1901 ) loosely hold outer flexible layer 1604 against inner structure 1602 , but still allow outer flexible layer 1604 to slide around the circumference of inner structure 1602 when inner structure 1602 expands.
- these arcuate ribs can encircle the entire circumference of inner structure 1602 .
- these arcuate ribs can partially encircle a portion of the circumference of inner structure 1602 .
- these arcuate ribs can expand or telescope longer when inner structure 1602 expands.
- outer flexible layer 1604 is between inner structure 1602 and a plurality of expandable arcuate ribs, wherein these ribs span all or part of the circumference of inner structure, and wherein the outer flexible layer can slide between the inner structure and the expandable arcuate ribs during expansion of the inner structure.
- a flexible third layer (such as a tubular net or mesh) can serve the same function as arcuate ribs, instead of using arcuate ribs.
- the wall of the device may be comprised of more than two layers.
- FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections.
- FIG. 22 shows this device before an inner structure ( 1602 ) has been expanded.
- the device shown in FIG. 22 comprises: inner structure ( 1602 ) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer ( 1604 ) that spans part of inner structure 1602 ; multiple points or seams (including 2201 and 2202 ) by which outer flexible layer 1604 is connected to inner structure 1602 ; and inflatable member 1603 which is used to expand inner structure 1602 .
- inner structure 1602 is again an expandable resilient tubular mesh and outer flexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602 .
- FIG. 22 shows this device before inner structure 1602 is expanded.
- FIG. 23 shows this device after inner structure 1602 has been expanded.
- FIG. 24 shows this device in a final configuration after inflatable member 1603 has been removed.
- a subset (including 2202 ) of multiple points or seams become disconnected when inner structure 1602 expands.
- the subset of points or seams (including 2201 ) which remain connected when inner structure 1602 expands help to keep outer flexible layer 1604 positioned over the aneurysm neck.
- the subset of multiple points or seams (including 2202 ) can become disconnected due to the shearing force of expansion.
- the subset of multiple points or seams can become disconnected via melting due to the application of an electrical charge.
- inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams, wherein these one or more of these points or seams are disconnected during expansion of the inner structure.
- this invention can be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage is lower than the first percentage.
- the second percentage can be at least 10% less than the first percentage.
Abstract
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 12/592,116—entitled “Stent with a Net Layer to Embolize an Aneurysm” filed on Nov. 18, 2009 by Robert Connor and Muhammad Tariq Janjua—the entirety of which is incorporated by reference.
- 1. Field of Invention
- This invention relates to devices to treat aneurysms.
- 2. Background and Review of Related Art
- An aneurysm is an abnormal bulging or ballooning of a blood vessel. Rupture of brain aneurysms can cause stroke, death, or disability. Around one-third of people who have a brain aneurysm that ruptures will die within 30 days of the rupture. Of the survivors, around half of them suffer some permanent loss of brain function. Many aneurysms are not identified until they rupture. However, identification of intact aneurysms is increasing due to increased outpatient imaging. Ruptured aneurysms must be treated to stop the bleeding or to prevent re-bleeding. Intact aneurysms may or may not be treated to prevent rupture, depending on their characteristics. Wide neck aneurysms are less prone to rupture, but are harder to treat. In the U.S., it has been estimated that over 10 million people have brain aneurysms and 30,000 people each year have a brain aneurysm that ruptures.
- Several approaches can be used to treat brain aneurysms. These different approaches can be divided into three categories: (1) approaches involving treatment outside the vessel; (2) approaches involving treatment inside the aneurysm; and (3) approaches involving treatment in the parent vessel. Some of these approaches can be used together. Each of these approaches has some disadvantages, as discussed below.
- Clipping: Clipping is the application of a small clip to the aneurysm neck from outside the vessel to seal off the aneurysm. For most brain aneurysms, this involves invasive surgery including removing a section of the skull. Clipping began in the 1930's and is well-established. Clipping is more common in the U.S. than in Europe. Around half of all aneurysms are treated by clipping. There are many aneurysm clips in the prior art. However, due to its invasive nature, clipping is decreasing. Potential disadvantages of clipping can include: significant health risks associated with major surgery of this type; and long recovery times, even when the surgery itself goes well.
- 2. Treatment Inside the Aneurysm
- Metal Coils: Metal coiling is the endovascular insertion of metal coils into the aneurysm to reduce blood flow and promote embolization in the aneurysm. Historically, metal coils have been platinum. Coils are more common in Europe than in the U.S. There are many examples of metal coils. Potential disadvantages of metal coils can include: low percentage of aneurysm volume filled (low occlusion is associated with a higher risk of rupture); compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty later clipping aneurysms filled with metal coils, if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
- Combination Metal/Textile/Foam/Gel Coils: Coils with a combination of metal and other materials can be used to try to achieve greater occlusion volume than metal coils alone. These other materials include textile, foam, and gel elements. Textile strands can be woven into the coils to add bulk. Coils can be covered with soft foam. Gel elements can be strung together into elongated structures. Examples of related art that appear to use this approach includes the following: U.S. Pat. Nos. 5,382,259 (Phelps et al.), 5,522,822 (Phelps et al.), 5,690,666 (Berenstein et al.), 5,718,711 (Berenstein et al.), 5,749,894 (Engelson), 5,976,162 (Doan et al.), 6,024,754 (Engelson), 6,299,619 (Greene, Jr. et al.), 6,602,261 (Greene, Jr. et al.), 6,723,108 (Jones et al.), 6,979,344 (Jones et al.), 7,070,609 (West), and 7,491,214 (Greene, Jr. et al.), and U.S. Patent Applications 20040158282 (Jones, Donald et al.), 20050267510 (Razack, Nasser), and 20060058834 (Do, Hiep et al.). Potential disadvantages of combination coils can include: remaining gaps between loops; compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty clipping aneurysms filled with coils with metal components later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils.
- Inflatable Balloons: Approximately two decades ago, there were numerous efforts to treat aneurysms by permanently filling them with inflatable balloons. These efforts were largely abandoned due to the risks of balloon deflation, prolapse into the parent vessel, aneurysm rupture, and recanalization. There are, however, examples of relatively recent art that appear to use inflatable balloons to treat aneurysms: U.S. Pat. Nos. 6,569,190 (Whalen et al.) and 7,083,643 (Whalen et al.), and U.S. Patent Applications 20030135264 (Whalen et al.), 20030187473 (Berenstein, Alejandro et al.), 20060292206 (Kim, Steven et al.), 20070050008 (Kim, Steven et al.), and 20070055355 (Kim, Steven et al.). Potential disadvantages of using inflatable balloons to permanently fill aneurysms can include: balloon deflation; prolapse of the balloon into the parent vessel; aneurysm rupture due to balloon pressure; and recanalization.
- Manually-Activated Mesh Occluders: Another approach to treating aneurysms involves inserting into the aneurysm a mesh structure, generally metal, that can be expanded or contracted by human-controlled mechanical motion so as to block the aneurysm neck and/or to fill the main volume of the aneurysm. For example, a wire structure can be inserted through the aneurysm neck in a narrow configuration and then transformed into an “hour-glass” shape that collapses to block the aneurysm neck when activated by a human controller. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,928,260 (Chin et al.), 6,344,048 (Chin et al.), 6,375,668 (Gifford et al.), 6,454,780 (Wallace), 6,746,468 (Sepetka et al.), 6,780,196 (Chin et al.), and 7,229,461 (Chin et al.), and U.S. Patent Applications 20020042628 (Chin, Yem et al.), 20020169473 (Sepetka, Ivan et al.), 20030083676 (Wallace, Michael), 20030181927 (Wallace, Michael), 20040181253 (Sepetka, Ivan et al.), 20050021077 (Chin et al.), 20060155323 (Porter, Stephen et al.), 20070088387 (Eskridge, Joseph et al.), 20070106311 (Wallace, Michael et al.), and 20080147100 (Wallace, Michael). Potential disadvantages of such manually-activated metal occluders include: difficulty engaging the necks of wide-neck aneurysms; difficulty filling irregularly-shaped aneurysms with standard-shaped mesh structures; risk of rupture when pinching the aneurysm neck or pushing on the aneurysm walls; and protrusion of the proximal portion of “hour-glass” designs into the parent vessel.
- Self-Expanding Standard-Shape Occluders: Another approach to treating aneurysms uses standard-shaped structures that self-expand when released into the aneurysm. For example, the structure may be a mesh of “shape memory” metal that automatically expands to a standard shape when released from the confines of the catheter walls. As another example, the structure may be a gel that expands to a standard shape when exposed to moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,766,219 (Horton), 5,916,235 (Guglielmi), 5,941,249 (Maynard), 6,409,749 (Maynard), 6,506,204 (Mazzocchi), 6,605,111 (Bose et al.), 6,613,074 (Mitelberg et al.), 6,802,851 (Jones et al.), 6,811,560 (Jones et al.), 6,855,153 (Saadat), 7,083,632 (Avellanet et al.), 7,306,622 (Jones et al.), and 7,491,214 (Greene, Jr. et al.), and U.S. Patent Applications 20030093097 (Avellanet, Ernesto et al.), 20030195553 (Wallace, Michael et al.), 20050033349 (Jones, Donald et al.), 20060052816 (Bates, Brian et al.), and 20060235464 (Avellanet, Ernesto et al.) and WIPO Patents WO/2006/084077 (Porter, Stephen et al.) and WO/1996/018343 (McGurk et. al.). Potential disadvantages of such self-expanding standard-shape structures can include: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
- Self-Expanding Custom-Modeled Occluders: A variation on self-expanding standard-shape occluders (discussed above) are self-expanding occluders that are custom modeled before insertion so as to fit the shape of a particular aneurysm. As an example sequence—the aneurysm can be imaged, the image is used to custom model the occluding structure, the occluding structure is compressed into a catheter, the occluding structure is inserted into the aneurysm, and the occluding structure then self-expands to fill the aneurysm. The occluding structure may be made from a gel that expands upon contact with moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,766,219 (Horton), 6,165,193 (Greene, Jr. et al.), 6,500,190 (Greene, Jr. et al.), 7,029,487 (Greene, Jr. et al.), and 7,201,762 (Greene, Jr. et al.), and U.S. Patent Application 20060276831 (Porter, Stephen et al.). Potential disadvantages of self-expanding custom-modeled occluders can include: the complexity and expense of imaging and modeling irregularly-shaped aneurysms; difficulty compressing larger-size structures into a catheter; difficulty inserting the occluding structure in precisely the correct position; and difficulty getting a gelatinous surface to anchor solidly to aneurysm walls.
- Congealing Liquid or Gel: Another approach to treating aneurysms involves filling an aneurysm with a liquid or gel that congeals rapidly. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,569,190 (Whalen et al.), 6,626,928 (Raymond et al.), 6,958,061 (Truckai et al.), and 7,083,643 (Whalen et al.), and U.S. Patent Application 20030135264 (Whalen et al.). Potential disadvantages of a congealing liquid or gel can include: leakage of the congealing substance into the parent vessel, potentially causing a stroke; difficulty filling the entire aneurysm if the substance begins to congeal before the aneurysm is full; and seepage of toxic substances into the blood stream.
- Biological or Pharmaceutical Agents: Biological and/or pharmaceutical agents can enhance the performance of a variety of mechanical treatment methods for aneurysms. For example, they can speed up the natural embolization process to occlude the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Patent Applications 20060206139 (Tekulve, Kurt J.), 20070168011 (LaDuca, Robert et al.), and 20080033341 (Grad, Ygael). Currently, biological and/or pharmaceutical approaches are not sufficient as stand alone treatment approaches for many cases. Accordingly, they share most of the potential disadvantages of the baseline approach to which the biological or pharmaceutical agents are added.
- Embolic-Emitting Expanding Members: Another approach involves an expanding member within the aneurysm that emits embolic elements into the aneurysm. Examples of such expanding members include bags, meshes, and nets. Examples of embolic elements include coils and congealing liquids. This can be viewed as another way to block the aneurysm neck while delivering embolics into the volume of the aneurysm. For example, the distal portion of an expanding bag may leak embolic elements into the aneurysm, but the proximal portion of the expanding member does not leak embolics into the parent vessel. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 6,547,804 (Porter et al.) and U.S. Patent Applications 20040098027 (Teoh, Clifford et al.), 20060079923 (Chhabra, Manik et al.), and 20080033480 (Hardert, Michael). Potential disadvantages are as follows. Since the expanding member “leaks,” it may have insufficient expansion force to adequately anchor against the aneurysm walls or to seal off the aneurysm neck. As a result of poor anchoring, the bag may prolapse into the parent vessel. Also, as a result of poor sealing of the aneurysm neck, embolics may leak into the parent vessel.
- Shape Memory Structures inside Expanding Members: A variation on the shape memory approach above involves the addition of an expanding member around the shape memory structure. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,861,003 (Latson et al.), 6,346,117 (Greenhalgh), 6,350,270 (Roue), 6,391,037 (Greenhalgh), and 6,855,153 (Saadat). The potential disadvantages of this approach are similar to those for uncovered shape memory occluders: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
- Accumulating Coils inside Expanding Members: A variation on the standard coiling approach above involves the addition of an expanding member around the accumulating coils. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,334,210 (Gianturco), 6,585,748 (Jeffree), and 7,153,323 (Teoh et al.), and U.S. Patent Applications 20060116709 (Sepetka, Ivan et al.), 20060116712 (Sepetka, Ivan et al.), and 20060116713 (Sepetka, Ivan et al.). Potential disadvantages of this approach are similar to those for coils alone, including: compaction of coils over time; risk of recanalization due to “bumpy” coil-filled expanding member; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability to treat all aneurysms; and expense of metal coils (especially platinum coils).
- 3. Treatment in the Parent Vessel
- Standard (High-Porosity) Stent: A stent is a structure that is inserted into a vessel in a collapsed form and then expanded into contact with the vessel walls. Standard stents are generally highly porous, metal, and cylindrical. A high-porosity stent allows blood to flow through the stent walls if there are any branching or secondary vessels in the vessel walls. Blood flow through a stent wall into a branching or secondary vessel is desirable, but blood flow through a stent wall into an aneurysm is not. Accordingly, a high-porosity stent in the parent vessel is not a good stand-alone aneurysm treatment. A high-porosity stent in the parent vessel can, however, help to keep coils or other embolic members from escaping out of the aneurysm into the parent vessel.
- Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,096,034 (Kupiecki et al., 2000), 6,344,041 (Kupiecki et al., 2002), 6,168,592 (Kupiecki et al., 2001), and 7,211,109 (Thompson, 2007). Potential disadvantages of this approach can include many of the problems associated with use of the embolic members alone. For example, using a high-porosity stent in the parent vessel in combination with coils in the aneurysm still leaves the following disadvantages of using coils alone: low percentage of aneurysm volume filled (and low occlusion is associated with a higher risk of rupture); compaction of coils over time; significant risk of recanalization; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
- Uniformly Low-Porosity Stent: Another approach involves inserting a uniformly low-porosity stent into the parent vessel. The low-porosity stent blocks the flow of blood through the stent walls into the aneurysm, causing beneficial embolization of the aneurysm. For example, the stent may have one or more layers that are impermeable to the flow of liquid. Unlike a standard (high-porosity) stent, this approach can be used as a stand-alone aneurysm treatment. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,645,559 (Hachtman et al., 1997), 5,723,004 (Dereume et al., 1998), 5,948,018 (Dereume et al., 1999), 6,165,212 (Dereume et al., 2000), 6,063,111 (Hieshima et al., 2000), 6,270,523 (Herweck et al., 2001), 6,331,191 (Chobotov, 2001), 6,342,068 (Thompson, 2002), 6,428,558 (Jones et al., 2002), 6,656,214 (Fogarty et al., 2003), 6,673,103 (Golds et al., 2004), 6,790,225 (Shannon et al., 2004), and 6,786,920 (Shannon et al., 2004), and U.S. Patent Application 20080319521 (Norris et al., 2008). Potential disadvantages of this approach can include: undesirably blocking blood flow to branching or secondary vessels that are close to the aneurysm and are covered by the stent wall; difficulty achieving a snug fit across the neck of the aneurysm if the parent vessel is curved, twisted, or forked; and poor attachment of the stent with the parent vessel wall due to the impermeable nature of the stent wall.
- Uniformly Intermediate-Porosity Metal Stent: This approach pursues creation of a stent with a uniform intermediate porosity that provides a compromise between the benefits of a high-porosity stent in the parent vessel (good blood flow to nearby branching or secondary vessels) and the benefits of a low-porosity stents in the parent vessel (blocking blood flow to the aneurysm). Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,770,087 (Layne et al., 2004), 7,052,513 (Thompson, 2006), and 7,306,624 (Yodfat et al., 2007), and U.S. Patent Applications 20070207186 (Scanlon et al.,2007), 20070219619 (Dieck et al., 2007), 20070276470 (Tenne, 2007), 20070276469 (Tenne, 2007), and 20080039933 (Yodfat et al., 2008). The main potential disadvantage of this approach is that it may perform neither function very well. It may unreasonably block flow to a branching or secondary vessels (causing a stroke) and may inadequately block blood flow to the aneurysm (leaving it vulnerable to rupture).
- Pre-Formed Differential Porosity Stent: This approach involves creating a stent with different levels of porosity for different wall areas, before the stent is inserted into the parent vessel. The goal is two-fold: (1) to place wall areas with high porosity over openings to branching or secondary vessels; and (2) to place wall areas with low porosity over the neck of the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,769,884 (Solovay,1998), 5,951,599 (McCrory, 1999), 6,309,367 (Boock, 2001), 6,309,413 (Dereume et al., 2001), 6,165,212 (Dereume et al., 2000), 5,948,018 (Dereume et al.,1999), 5,723,004 (Dereume et al., 1998), and 7,186,263 (Golds et al., 2007), and U.S. Patent Applications 20070219610 (Israel, 2007), 20070239261 (Bose, et al., 2007), and 20080004653 (Sherman et al., 2008). Potential disadvantages of this approach include: difficultly matching a specific anatomic configuration (curvature, branching, neck size, etc) with a preformed stent; difficulty of precise placement of the stent to properly align the porous and non-porous areas with branching vessels and the aneurysm, respectively; and difficulty creating low porosity areas in a compressed state that maintain this low porosity in an expanded state.
- Post-Implantation Filling Between Stent Wall and Vessel Wall: This approach fills the gap between the wall of the stent and the wall of the parent vessel with an embolizing substance such as a liquid or gel that solidifies after insertion. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,769,882 (Fogarty et al., 1998) and U.S. Patent Application 20070150041 (Evans et al., 2007). Potential disadvantages of this approach include: difficulty injecting the embolizing substance through the stent wall without having it leak back into the parent vessel; leakage of embolizing liquid or gel between the stent and the parent vessel into the blood stream, where it blocks a downstream vessel and causes a stroke; challenges containing the embolic material within curving vessels or vessels with irregular walls; and difficulty using this method to fill narrow-neck aneurysms.
- Post-Implantation Surface Modification: This approach creates different degrees of porosity in different wall areas after the stent is implanted. The goal is to decrease the porosity of the stent wall in the area of the aneurysm neck, but to leave the rest of the stent wall relatively porous to allow blood flow to branching or secondary members. Also, high porosity in other areas of the stent wall aids in the attachment and integration of the stent to the parent vessel. Unlike the preceding approach, this approach does not fill the gap between the stent wall and the parent vessel wall with some type of solidifying liquid, but rather modifies the wall of the stent itself This reduces the risk of embolic liquid or members leaking out between the stent and the parent vessel wall into the blood stream.
- This approach remains relatively uncommon The few examples in the related art appear to expose one area of the stent wall to surface-modifying chemicals or energy emissions in order to decrease porosity of the stent wall in that area alone. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,951,599 (McCrory, 1999) and 7,156,871 (Jones et al., 2007). Potential disadvantages of this approach include: negative effects of surface-modifying chemicals seeping into the blood stream; negative effects of energy emissions on surrounding vessel or brain tissue; and difficulty adding enough matter to the stent wall covering the aneurysm neck by chemical or energy modification means, after stent implantation, to adequately reduce blood flow through the aneurysm neck.
- To conclude this section, although there has been significant progress in developing options for treating brain aneurysms, there are still high rates of death and disability and still disadvantages to the treatment options available.
- This invention can be embodied in a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm. The stent wall includes an inner structure, such as an expandable metal mesh, that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer, such as a flexible fabric net, that covers all or part of the inner structure. Embolic members are placed and retained in the gap between the inner structure and the outer layer in the area of the aneurysm neck in order to reduce blood flow to the aneurysm.
- This invention can also be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage less than the first percentage.
-
FIGS. 1 through 24 show possible embodiments of this stent, but do not limit the full generalizability of the claims. -
FIG. 1 shows an opaque side view of one embodiment of this stent after it has been inserted and expanded within the parent blood vessel of an aneurysm. -
FIG. 2 shows an alternative view of this same embodiment, with the two layers of the stent being transparent in order to allow a clearer view of the guidewires. -
FIG. 3 shows an opaque side view of this same embodiment, except that a catheter to deliver embolic members has now been slid along the guidewires to reach an opening in the inner mesh structure. -
FIG. 4 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members. -
FIG. 5 shows an opaque side view of this same embodiment, except that a plurality of embolic members have now been inserted into the gap between the inner mesh structure and the outer flexible layer in the area of the aneurysm neck. -
FIG. 6 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members. -
FIGS. 7 and 8 show this same embodiment after the detachment and withdrawal of the guidewires and catheter. -
FIG. 9 shows a close-up view of guidewires attached to the inside surface of a hexagonal opening in the inner mesh structure. -
FIG. 10 shows a close-up view of the distal end of the catheter as it slides along the guidewires toward the inner mesh structure. -
FIG. 11 shows a close-up view of the distal end of the catheter after it has completely slid along the guidewires to reach the inner mesh structure and be aligned with an opening in this inner mesh structure. -
FIG. 12 shows a close-up view of embolic members being propelled through the catheter by a flow of sterile saline solution. -
FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure and the outer flexible layer, with both guidewires and catheter having been withdrawn. -
FIGS. 14 and 15 show examples of this stent with a high-flexibility area of the outer flexible layer that is identified by radioopaque lines and that is positioned to cover the aneurysm neck. -
FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs. -
FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs. -
FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections. -
FIGS. 1 through 24 show possible embodiments of this stent. However, these embodiments are not exhaustive. These figures do not limit the full generalizability of the claims. -
FIG. 1 shows an opaque side view of one embodiment of this stent, after it has been inserted and expanded within the parent blood vessel of an aneurysm.FIG. 1 also shows a cross-sectional side view of theparent blood vessel 103 withaneurysm 101 includinganeurysm neck 102. In this embodiment, the stent system has a resilientinner structure 104, which is a metal mesh with a hexagonal pattern, and an outerflexible layer 105 that is configured like a net around the inner structure.FIG. 1 also shows twoguidewires 106 that are attached toinner structure 104. The stent is shown inFIG. 1 in an already inserted and expanded configuration. Many methods of stent insertion and expansion, such as by catheter and balloon, are well known in the art and the precise methods of insertion and expansion are not central to this invention. - In this embodiment, the wall of the stent consists of two layers. The inner layer of the stent wall is an expandable and resilient
metal mesh structure 104 with a hexagonal pattern. Many other types of expandable mesh structures may also be used. In various examples, this inner mesh structure may be made from stainless steel, a nickel-titanium alloy, cobalt chromium or a cobalt-chromium alloy, titanium or a titanium alloy, tantalum or a tantalum allow, or polymeric-based resin or another polymer. In this embodiment, the outer layer of the stent is aflexible fabric net 105. In various examples, the outer flexible layer may be made from latex, nylon, polyester, teflon, silicone, HDPE, polycarbonate urethane, polyether-polyamide copolymer, polyethylene terephthalate, polyolefin, polypropylene, polytetrafluorethylene, polytetrafluoroethene, polyurethane, or polyvinyl chloride. - In this embodiment, there is a gap between the inner mesh structure and the outer flexible layer and these layers are not connected to each other. In other examples of this invention, there may be no gap between these layers until embolic members are inserted between them in the area of the aneurysm neck. In other examples, the two layers may be connected at multiple points or seams in order to form separate pouches between the layers for more precise localized containment of the embolic members between the layers. In other examples, the wall may be comprised of more than two layers.
-
FIG. 2 shows an alternative view of the same embodiment of this stent that is shown inFIG. 1 .FIG. 2 is the same asFIG. 1 except thatFIG. 2 shows the two layers of the stent as transparent in order to allow a clearer view of twoguidewires 106 that are attached to the inner mesh structure of the stent wall. In this embodiment, these twoguidewires 106 were attached to the inner structure of the stent at a specific point before insertion of the stent and the operator has aligned this point with theaneurysm neck 102 during stent placement within theparent vessel 103. In this embodiment, these twoguidewires 106 will be used to guide a catheter that delivers embolic members into the gap between theinner wall structure 104 and the outerflexible layer 105. In another example, guidewires need not be used; the catheter may be directed to the inner wall structure using real-time imaging and attached to the inner wall structure with a grasping or hooking mechanism. -
FIG. 3 shows an opaque side view of the same embodiment of this stent that is shown inFIG. 1 , except that acatheter 301 to deliver embolic members (including embolic member 302) has been slid alongguidewires 106 to reach an opening in theinner mesh structure 104. In this embodiment, sterile embolic members (including 302) are propelled by a flow of sterile saline solution throughcatheter 301 for insertion into the gap betweeninner mesh structure 104 and outerflexible layer 105. The saline solution propels the embolic members through the catheter and into the gap, wherein the members expand and are trapped within the gap. The saline solution escapes through the openings in the mesh. In other examples, other means may be used to transport the embolic members along the catheter, such as miniature conveyor belts or rotating helix mechanisms. - In this embodiment, the embolic members are compressible micro-sponges that expand upon ejection from the catheter. In various examples, these micro-sponges may be made from cellulose, collagen, acetate, alginic acid, carboxy methyl cellulose, chitin, collagen glycosaminoglycan, divinylbenzene, ethylene glycol, ethylene glycol dimethylmathacrylate, ethylene vinyl acetate, hyaluronic acid, hydrocarbon polymer, hydroxyethylmethacrylate, methlymethacrylate, polyacrylic acid, polyamides, polyesters, polyolefins, polysaccharides, polyurethane, polyvinyl alcohol, silicone, urethane, and vinyl stearate. In other examples, the embolic members may be gels, beads, or coils.
- In this embodiment, the embolic members (such as 302) are retained with the gap between the
inner mesh structure 104 and outerflexible layer 105 because they expand upon ejection from thecatheter 301 and can not exit the same opening in the inner mesh structure by which they entered this gap. In another example, the embolic members need not expand, but the opening by which they enter the gap may be closed when the catheter is removed to trap them within the gap. -
FIG. 4 shows an alternative view of the same embodiment of this stent that is shown inFIG. 3 , except that the two layers of the stent are transparent in order to allow a clearer view ofcatheter 301 and embolic members (including 302). -
FIG. 5 shows an opaque side view of the same embodiment of this stent that is shown inFIG. 3 , except that a plurality of embolic members (including 302) have now been delivered viacatheter 301 and inserted into the gap between theinner mesh structure 104 and the outerflexible layer 105 in the area of the aneurysm neck. The flexibility ofouter layer 105 allows it to distend into the aneurysm neck to more thoroughly block blood flow through the neck. A sufficient volume of embolic members has been inserted into this gap in the area of the aneurysm neck to occlude the flow of blood intoaneurysm 101, thereby promoting embolization of the aneurysm. -
FIG. 6 shows an alternative view of the same embodiment of this stent that is shown inFIG. 5 , except that the two layers of the stent are transparent in order to allow a clearer view ofcatheter 301 and embolic members (including 302). -
FIGS. 7 and 8 show the same embodiment, but after the detachment and withdrawal of theguidewires 106 andcatheter 301. In this example, the guidewires may be detached from the inner mesh structure by application of a mild electric current and the catheter may be removed by simple mechanical withdrawal. Many other methods for detaching and removing guidewires and catheters are known in the prior art and the exact detachment and removal mechanisms are not central to this invention. Blood flow through the aneurysm neck is now largely blocked to promote embolization of the aneurysm, but other areas of the stent remain largely porous to foster integration with the walls of the parent vessel and to allow blood flow to any secondary vessels that may branch off from the parent vessel along the length of the stent. -
FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall. In these figures: only small square patches ofinner mesh structure 104 and outerflexible layer 105 are shown (indicated by dashed line borders); and the size of the gap between these two layers is exaggerated to provide a clearer view of how embolic members are inserted within this gap. In this example,guidewires 106 are attached toinner mesh structure 104 before the stent is inserted in the parent vessel andcatheter 301 is guided to theinner mesh structure 104 by means of these guidewires. -
FIG. 9 shows a close-up view ofguidewires 106 attached to the inside surface of a hexagonal opening ininner mesh structure 104.FIG. 9 also shows outerflexible layer 105.FIG. 9 corresponds to a close-up view of a small area ofFIGS. 1 and 2 , the area in which guidewires 106 are attached toinner mesh structure 104.FIG. 10 shows a close-up view of thedistal end 1001 ofcatheter 301 as it slides alongguidewires 106 towardinner mesh structure 104. The other (proximal) end ofcatheter 301 remains outside the person's body. There are two holes, including 1002, that run longitudinally through opposite sides of the wall ofcatheter 301 and containguidewires 106, enablingcatheter 301 to slide alongguidewires 106.FIG. 11 shows a close-up view of thedistal end 1001 ofcatheter 301 after it has completely slid alongguidewires 106 to reachinner mesh structure 104 and be aligned with one hexagonal opening of this structure. -
FIG. 12 shows a close-up view of embolic members (including 302) being propelled throughcatheter 301 by a flow of sterile saline solution. In this example, the embolic members are micro-sponges that expand upon ejection from the catheter into the gap between theinner mesh structure 104 and outerflexible layer 105.FIG. 12 corresponds to a close-up view of a small area ofFIGS. 3 and 4 , the area in which theguidewires 106 are attached to theinner mesh structure 104. -
FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between theinner mesh structure 104 and outerflexible layer 105. Also,guidewires 106 andcatheter 301 have been detached and withdrawn.FIG. 13 corresponds to a close-up view of a small area ofFIGS. 7 and 8 , the area in which the guidewires were attached to the inner mesh structure. -
FIGS. 14 and 15 show an opaque side view of two examples of this stent that feature an outer flexible layer with differential flexibility. Having a stent with one area of the outer flexible layer that has greater flexibility and placing this area over the aneurysm neck has two advantages. First, it facilitates insertion of a substantial mass of embolic members into the gap between the inner mesh and the outer flexible layer in the area of the aneurysm neck in order to thoroughly occlude the aneurysm neck. Second, although the walls of the parent vessel resist migration of embolic members through the gap away from the aneurysm neck area, having less flexibility of the outer layer outside the aneurysm neck area provides additional resistance to possible migration of embolic members. - Specifically,
FIGS. 14 and 15 show a stent, with an innerstructural mesh 104 and an outerflexible net 105, having been inserted intoparent vessel 103 ofaneurysm 101 withaneurysm neck 102.FIGS. 14 and 15 also show a saddle-shapedarea 1401 of the outer flexible net that has greater flexibility than the rest of the net. This saddle-shaped area with greater flexibility is positioned to cover the aneurysm neck when the stent is placed and expanded. - In
FIGS. 14 and 15 , the stent also features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion of the stent. InFIG. 14 , the saddle-shapedarea 1401 is identified for the operator by radioopaque longitudinal lines (including 1402) and lateral circumferential lines (including 1403) that intersect the outer boundaries of the saddle-shaped area. In this example, the operator positions the stent so that the aneurysm neck is centered, in each direction, between these radioopaque lines. InFIG. 15 , the saddle-shapedarea 1401 is identified by radioopaquelongitudinal line 1501 and lateralcircumferential line 1502 that intersect the center of the saddle-shaped area. In this example, the operator positions the stent so that the intersection of these lines is centered within the aneurysm neck. - In the examples shown in
FIGS. 14 and 15 : there is only one area of the outer flexible net with higher flexibility, this area is saddle-shaped, and this area spans approximately 15% of surface area of the stent. In other examples: there may be more than one area with higher flexibility to address multiple aneurysms, the area may have a different shape, and the area may span a higher or lower percentage of the surface area of the stent. In these examples, the radioopaque lines are lateral circumferential and longitudinal lines. In other examples, the radioopaque lines may trace the exact perimeter of the higher-flexibility area. - The following are particularly-relevant quotes from the specification thus far (including page and line numbers from the original Nov. 18, 2009 specification): “a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm” (Nov. 18, 2009 specification, page 10, lines 23-25); “stent wall includes an inner structure . . . that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer . . . that covers . . . part of the inner structure” (Nov. 18, 2009 specification, page 10, lines 25-27); “one area of the outer flexible net . . . the area may span a higher or lower percentage of the surface area of the stent” (Nov. 18, 2009 specification, page 17, line 28-page 18, line 1); “features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion ” (Nov. 18, 2009 specification, page 17, lines 17-19); “layers may be connected at multiple points or seams” (Nov. 18, 2009 specification, page 13, lines 30-31); and “In this embodiment . . . these layers are not connected to each other” (Nov. 18, 2009 specification, page 13, lines 27-28).
- In an example, an invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein this outer flexible layer spans a first percentage of the surface area of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the surface area of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage. In an example, the outer flexible layer can be less porous than the inner structure. In an example, this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
- In an example, this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein the inner structure and outer flexible layer are connected to each other at multiple points or seams, and wherein one or more of these multiple points or seams are disconnected during expansion of the inner structure. In an example, the outer flexible layer can be less porous than the inner structure. In an example, this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
-
FIGS. 16 through 24 show three examples of how this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that spans a first percentage of the circumference of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the circumference of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage. -
FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs.FIG. 16 shows a longitudinal cross-sectional view ofaneurysm 1601 and a longitudinal cross-sectional view of the parent vessel of the aneurysm.FIG. 16 also shows a longitudinal side view of a device that has been inserted into the parent vessel ofaneurysm 1601.FIG. 16 shows this device after the device has been placed within the parent vessel and after an outer flexible layer (1604) has been aligned with the neck of the aneurysm, but before an inner structure (1602) has been expanded. In this example, this device comprises: inner structure (1602) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer (1604) that spans part ofinner structure 1602; multiple points or seams (including 1605 and 1606) by which outerflexible layer 1604 is connected toinner structure 1602; multiple arcuate ribs ortracks 1607 to which the multiple points or seams (including 1605 and 1606) are attached; andinflatable member 1603 which is used to expandinner structure 1602. - In this example,
inner structure 1602 is an expandable resilient tubular mesh. In this example, outerflexible layer 1604 is a saddle-shaped net, patch, covering, and/or liner with a lower porosity thaninner structure 1602. In an example, outerflexible layer 1604 can have smaller surface pores or openings (as shown inFIGS. 9 through 13 ) and/or be less permeable to blood thaninner structure 1602. In an example, outerflexible layer 1604 can be impermeable to blood. In various examples, outerflexible layer 1604 can have shapes other than a saddle shape. In an example, outerflexible layer 1604 can have a semi-tubular shape. In this example, outerflexible layer 1604 spans a first percentage of the circumference ofinner structure 1602 before expansion ofinner structure 1602. In this example, outerflexible layer 1604 spans (a maximum of) approximately 75% of the circumference ofinner structure 1602 before expansion ofinner structure 1602. In other examples, an outer flexible layer can span a pre-expansion percentage of the circumference of the inner structure in the range of 50% to 100%. - In an example, arcuate ribs or tracks (such as 1607) can encircle the entire circumference of
inner structure 1602. In an example, arcuate ribs or tracks (such as 1607) can partially encircle a portion of the circumference ofinner structure 1602. In an example, arcuate ribs or tracks can fully or partially encircle the circumference ofinner structure 1602 in a plane which is substantially perpendicular to the longitudinal axis ofinner structure 1602. In an example, arcuate ribs or tracks (such as 1607) can expand or telescope longer wheninner structure 1602 expands. - In an example,
inflatable member 1603 can be a balloon. In an example,inflatable member 1603 can be inflated by filling it with a liquid, such as saline or contrast media. In an example,inflatable member 1603 can be inflated by filling it with a gas, such as carbon dioxide. In an example, this device can further comprise imaging-detectable markings (as shown inFIGS. 14 and 15 ) to help an operator align outerflexible layer 1604 with the neck of the aneurysm. In an example, this device can further comprise radioopaque markings to help an operator align outerflexible layer 1604 with the neck of the aneurysm. In an example, this device can further comprise ultrasound-detectable markings to help an operator align outerflexible layer 1604 with the neck of the aneurysm. In an example, three-dimensional ultrasound imaging can be used to guide placement of the device and/or to align theouter layer 1604 with the neck of the aneurysm. -
FIG. 16 shows this device beforeinner structure 1602 is expanded by expansion ofinflatable member 1603.FIG. 17 shows this same device afterinner structure 1602 has been expanded by expansion ofinflatable member 1603. As shown inFIG. 17 , the (maximum) percentage of the surface area ofinner structure 1602 which is spanned by outerflexible layer 1604 is smaller after expansion ofinner structure 1602. This is because outerflexible layer 1604 has been expanded less, or not at all, during the expansion ofinner structure 1602. As also shown inFIG. 17 , the (maximum) percentage of the circumference ofinner structure 1602 which is spanned by outerflexible layer 1604 is smaller after the expansion ofinner structure 1602. This is because outerflexible layer 1604 has been expanded less, or not at all, during the expansion ofinner structure 1602. In this example, the post-expansion percentage of the circumference ofinner structure 1602 which is spanned by outerflexible layer 1604 is approximately 30%. In an example, this percentage can be in the range of 20% to 60% - As shown in
FIGS. 16 and 17 , outerflexible layer 1604 spans a first (pre-expansion) percentage of the circumference ofinner structure 1602 beforeinner structure 1602 is expanded, spans a second (post-expansion) percentage of the circumference ofinner structure 1602 after inner structure is expanded, and the first percentage is larger than the second percentage. This is because the surface area of the outerflexible layer 1604 expands less (or not at all) relative to the expansion ofinner structure 1602. This differential expansion of outerflexible layer 1604 vs.inner structure 1602 creates a region of low-porosity over the aneurysm neck. This advantageously helps to block blood flow through the aneurysm without deleteriously blocking blood flow to nearby branching blood vessels (such as the small branching vessel shown on side of the parent vessel which is opposite the aneurysm neck). - In the example shown in
FIGS. 16 and 17 , outerflexible layer 1604 has less expansion (or none at all) compared to the expansion ofinner structure 1602 because outerflexible layer 1604 is connected toinner structure 1602 by means of multiple points or seams (such as 1605 and 1606) which are able to slide along multiple arcuate ribs or tracks (such as 1607) along the circumference ofinner structure 1602. In this example, wheninner structure 1602 is expanded, outerflexible layer 1604 does not expand. In this example, wheninner structure 1602 is expanded, outerflexible layer 1604 slides on the arcuate ribs or tracks via multiple points or seams (including 1606). This is why, in this example, outer flexible layer 1604 (which does not expand) covers a smaller percentage of the surface area of inner structure 1602 (which does expand) afterinner structure 1602 has been expanded. - In an example,
inner structure 1602 and outerflexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move along the circumference of the inner structure during expansion of the inner structure. In an example,inner structure 1602 and outerflexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move on a track along the circumference of the inner structure during expansion of the inner structure. - In the example shown in
FIGS. 16 and 17 , a first subset (including 1606) of the multiple points or seams can slide along arcuate ribs or tracks (such as 1607) wheninner structure 1602 expands, but a second subset (including 1605) of the multiple points or seams does not slide. Having a first subset (including 1606) of multiple points or seams slide allows outerflexible layer 1604 to not expand wheninner structure 1602 expands. Having a second subset (including 1605) of multiple points or seams which do not slide helps to keep outerflexible layer 1604 properly positioned over the aneurysm neck during expansion ofinner structure 1602.FIG. 18 shows the same device that was shown inFIGS. 16 and 17 , but in a final configuration afterinflatable member 1603 has been removed. -
FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs.FIG. 19 shows this device before inner structure (1602) has been expanded. The device shown inFIG. 19 comprises: inner structure (1602) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer (1604) that spans part ofinner structure 1602; multiple arcuate ribs (including 1901) outside outerflexible layer 1604; andinflatable member 1603 which is used to expandinner structure 1602. Similar to the previous example,inner structure 1602 is an expandable resilient tubular mesh. Also, outerflexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity thaninner structure 1602.FIG. 19 shows this device beforeinner structure 1602 is expanded.FIG. 20 shows this device afterinner structure 1602 has been expanded.FIG. 21 shows this device in a final configuration afterinflatable member 1603 has been removed. - However, in this example, arcuate ribs (such as 1901) are outside outer
flexible layer 1604. In this example, arcuate ribs (such as 1901) loosely hold outerflexible layer 1604 againstinner structure 1602, but still allow outerflexible layer 1604 to slide around the circumference ofinner structure 1602 wheninner structure 1602 expands. In an example, these arcuate ribs can encircle the entire circumference ofinner structure 1602. In an example, these arcuate ribs can partially encircle a portion of the circumference ofinner structure 1602. In an example, these arcuate ribs can expand or telescope longer wheninner structure 1602 expands. In an example, outerflexible layer 1604 is betweeninner structure 1602 and a plurality of expandable arcuate ribs, wherein these ribs span all or part of the circumference of inner structure, and wherein the outer flexible layer can slide between the inner structure and the expandable arcuate ribs during expansion of the inner structure. In an alternative example, the use of a flexible third layer (such as a tubular net or mesh) can serve the same function as arcuate ribs, instead of using arcuate ribs. In an example, the wall of the device may be comprised of more than two layers. -
FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections.FIG. 22 shows this device before an inner structure (1602) has been expanded. The device shown inFIG. 22 comprises: inner structure (1602) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer (1604) that spans part ofinner structure 1602; multiple points or seams (including 2201 and 2202) by which outerflexible layer 1604 is connected toinner structure 1602; andinflatable member 1603 which is used to expandinner structure 1602. Similar to the previous example,inner structure 1602 is again an expandable resilient tubular mesh and outerflexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity thaninner structure 1602.FIG. 22 shows this device beforeinner structure 1602 is expanded.FIG. 23 shows this device afterinner structure 1602 has been expanded.FIG. 24 shows this device in a final configuration afterinflatable member 1603 has been removed. - In this example, a subset (including 2202) of multiple points or seams (including 2201 and 2202) become disconnected when
inner structure 1602 expands. This is another way to allowinner structure 1602 to expand without making outerflexible layer 1604 also expand. The subset of points or seams (including 2201) which remain connected wheninner structure 1602 expands help to keep outerflexible layer 1604 positioned over the aneurysm neck. This is another way to create a low-porosity region over the aneurysm neck to block blood flow to the aneurysm without blocking blood flow to nearby branching vessels. In an example, the subset of multiple points or seams (including 2202) can become disconnected due to the shearing force of expansion. In an example, the subset of multiple points or seams (including 2202) can become disconnected via melting due to the application of an electrical charge. In an example,inner structure 1602 and outerflexible layer 1604 can be connected at multiple points or seams, wherein these one or more of these points or seams are disconnected during expansion of the inner structure. - In an example, this invention can be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage is lower than the first percentage. In an example, the second percentage can be at least 10% less than the first percentage.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/562,725 US9358140B1 (en) | 2009-11-18 | 2014-12-07 | Stent with outer member to embolize an aneurysm |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/592,116 US20100131002A1 (en) | 2008-11-24 | 2009-11-18 | Stent with a net layer to embolize and aneurysm |
US14/562,725 US9358140B1 (en) | 2009-11-18 | 2014-12-07 | Stent with outer member to embolize an aneurysm |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/592,116 Continuation-In-Part US20100131002A1 (en) | 2008-11-24 | 2009-11-18 | Stent with a net layer to embolize and aneurysm |
Publications (2)
Publication Number | Publication Date |
---|---|
US20160151177A1 true US20160151177A1 (en) | 2016-06-02 |
US9358140B1 US9358140B1 (en) | 2016-06-07 |
Family
ID=56078439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/562,725 Expired - Fee Related US9358140B1 (en) | 2009-11-18 | 2014-12-07 | Stent with outer member to embolize an aneurysm |
Country Status (1)
Country | Link |
---|---|
US (1) | US9358140B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150216684A1 (en) * | 2012-08-17 | 2015-08-06 | The Regents Of The University Of California | Dual rotational stent apparatus and method for endovascular treatment of aneurysms |
US20160220396A1 (en) * | 2011-09-09 | 2016-08-04 | Isis Innovation Limited | Stent and method of inserting a stent into a delivery catheter |
EP4138741A4 (en) * | 2020-04-20 | 2023-12-27 | Exovitra LLC | Methods and systems for treatment of aneurysms |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3051684C (en) | 2011-12-06 | 2020-06-16 | Aortic Innovations Llc | Device for endovascular aortic repair and method of using the same |
EP3668417B1 (en) | 2017-08-17 | 2022-10-05 | Arissa Medical, Inc. | Flow attenuation device |
WO2019195540A2 (en) | 2018-04-04 | 2019-10-10 | Incumedx, Inc. | Embolic device with improved neck coverage |
Family Cites Families (659)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4364392A (en) | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4958634A (en) | 1987-05-06 | 1990-09-25 | Jang G David | Limacon geometry balloon angioplasty catheter systems and method of making same |
US4994069A (en) | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5405379A (en) | 1990-07-26 | 1995-04-11 | Lane; Rodney J. | Self expanding vascular endoprosthesis for aneurysms |
IT9084979A1 (en) | 1990-07-30 | 1992-01-31 | Imad Sheiban | PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTIC CATHETER WITH TWO BALLOONS AT ITS DISTAL END ONE OF SMALL DIAMETER (1, 5MM. FOLLOWED BY ANOTHER BALLOON OF GREATER DIAMETER VARIABLE FROM 2, 5 TO 4 MM THE BALLOON THE SMALL BALLOON |
JP3356447B2 (en) | 1991-10-16 | 2002-12-16 | テルモ株式会社 | Vascular lesion embolic material composed of dried polymer gel |
ATE247435T1 (en) | 1992-05-08 | 2003-09-15 | Schneider Usa Inc | STENT FOR THE OESOPHAGUS |
US5443478A (en) | 1992-09-02 | 1995-08-22 | Board Of Regents, The University Of Texas System | Multi-element intravascular occlusion device |
US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5690666A (en) | 1992-11-18 | 1997-11-25 | Target Therapeutics, Inc. | Ultrasoft embolism coils and process for using them |
US5370691A (en) | 1993-01-26 | 1994-12-06 | Target Therapeutics, Inc. | Intravascular inflatable stent |
US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5925059A (en) | 1993-04-19 | 1999-07-20 | Target Therapeutics, Inc. | Detachable embolic coil assembly |
US5800453A (en) | 1993-04-19 | 1998-09-01 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking hooks and slots |
US5411549A (en) | 1993-07-13 | 1995-05-02 | Scimed Life Systems, Inc. | Selectively expandable, retractable and removable stent |
US6025044A (en) | 1993-08-18 | 2000-02-15 | W. L. Gore & Associates, Inc. | Thin-wall polytetrafluoroethylene tube |
US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
US5423829A (en) | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
US5624449A (en) | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
WO1995013033A1 (en) | 1993-11-08 | 1995-05-18 | Lazarus Harrison M | Intraluminal vascular graft and method |
US5795331A (en) | 1994-01-24 | 1998-08-18 | Micro Therapeutics, Inc. | Balloon catheter for occluding aneurysms of branch vessels |
US6140452A (en) | 1994-05-06 | 2000-10-31 | Advanced Bio Surfaces, Inc. | Biomaterial for in situ tissue repair |
US5536252A (en) | 1994-10-28 | 1996-07-16 | Intelliwire, Inc. | Angioplasty catheter with multiple coaxial balloons |
IL116561A0 (en) | 1994-12-30 | 1996-03-31 | Target Therapeutics Inc | Severable joint for detachable devices placed within the body |
US6579314B1 (en) | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US5911731A (en) | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US5639277A (en) | 1995-04-28 | 1997-06-17 | Target Therapeutics, Inc. | Embolic coils with offset helical and twisted helical shapes |
US6143007A (en) | 1995-04-28 | 2000-11-07 | Target Therapeutics, Inc. | Method for making an occlusive device |
US5833657A (en) | 1995-05-30 | 1998-11-10 | Ethicon, Inc. | Single-walled balloon catheter with non-linear compliance characteristic |
US5624461A (en) | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
US5766160A (en) | 1995-06-06 | 1998-06-16 | Target Therapeutics, Inc. | Variable stiffness coils |
NO962336L (en) | 1995-06-06 | 1996-12-09 | Target Therapeutics Inc | Vaso-occlusive spiral |
US5603722A (en) | 1995-06-06 | 1997-02-18 | Quanam Medical Corporation | Intravascular stent |
US5582619A (en) | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
DK0754435T3 (en) | 1995-06-30 | 2000-11-27 | Target Therapeutics Inc | Stretch-resistant co-occlusion spirals |
US5853418A (en) | 1995-06-30 | 1998-12-29 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
US6013084A (en) | 1995-06-30 | 2000-01-11 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
US5743905A (en) | 1995-07-07 | 1998-04-28 | Target Therapeutics, Inc. | Partially insulated occlusion device |
US5785679A (en) | 1995-07-19 | 1998-07-28 | Endotex Interventional Systems, Inc. | Methods and apparatus for treating aneurysms and arterio-venous fistulas |
US5888546A (en) | 1995-08-28 | 1999-03-30 | The Regents Of The University Of California | Embolic material for endovascular occlusion of abnormal vasculature and method for using the same |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US6689162B1 (en) | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
EP0775471B1 (en) | 1995-11-27 | 2002-05-29 | Schneider (Europe) GmbH | A stent for use in a body passage way |
US6579305B1 (en) | 1995-12-07 | 2003-06-17 | Medtronic Ave, Inc. | Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material |
US5749894A (en) | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
US6428571B1 (en) | 1996-01-22 | 2002-08-06 | Scimed Life Systems, Inc. | Self-sealing PTFE vascular graft and manufacturing methods |
US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US5702361A (en) | 1996-01-31 | 1997-12-30 | Micro Therapeutics, Inc. | Method for embolizing blood vessels |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US6796997B1 (en) | 1996-03-05 | 2004-09-28 | Evysio Medical Devices Ulc | Expandable stent |
US5649949A (en) | 1996-03-14 | 1997-07-22 | Target Therapeutics, Inc. | Variable cross-section conical vasoocclusive coils |
US5868780A (en) | 1996-03-22 | 1999-02-09 | Lashinski; Robert D. | Stents for supporting lumens in living tissue |
NZ331269A (en) | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
US5718159A (en) | 1996-04-30 | 1998-02-17 | Schneider (Usa) Inc. | Process for manufacturing three-dimensional braided covered stent |
US6592617B2 (en) | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US6190402B1 (en) | 1996-06-21 | 2001-02-20 | Musc Foundation For Research Development | Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same |
US5769884A (en) | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5928279A (en) | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US6096034A (en) | 1996-07-26 | 2000-08-01 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
US5968069A (en) | 1996-08-23 | 1999-10-19 | Scimed Life Systems, Inc. | Stent delivery system having stent securement apparatus |
US5964797A (en) | 1996-08-30 | 1999-10-12 | Target Therapeutics, Inc. | Electrolytically deployable braided vaso-occlusion device |
US5941249A (en) | 1996-09-05 | 1999-08-24 | Maynard; Ronald S. | Distributed activator for a two-dimensional shape memory alloy |
US6254628B1 (en) | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
US6007573A (en) | 1996-09-18 | 1999-12-28 | Microtherapeutics, Inc. | Intracranial stent and method of use |
WO1998011847A1 (en) | 1996-09-20 | 1998-03-26 | Houser Russell A | Radially expanding prostheses and systems for their deployment |
US5690667A (en) | 1996-09-26 | 1997-11-25 | Target Therapeutics | Vasoocclusion coil having a polymer tip |
US6086610A (en) | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US6984240B1 (en) | 1996-10-25 | 2006-01-10 | Target Therapeutics, Inc. | Detachable multidiameter vasoocclusive coil |
US7591846B2 (en) | 1996-11-04 | 2009-09-22 | Boston Scientific Scimed, Inc. | Methods for deploying stents in bifurcations |
AU4896797A (en) | 1996-11-04 | 1998-05-29 | Davidson, Charles | Extendible stent apparatus and method for deploying the same |
US6325826B1 (en) | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6599316B2 (en) | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6835203B1 (en) | 1996-11-04 | 2004-12-28 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
EP1230902A1 (en) | 1996-11-15 | 2002-08-14 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
US6010529A (en) | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
US5776097A (en) | 1996-12-19 | 1998-07-07 | University Of California At Los Angeles | Method and device for treating intracranial vascular aneurysms |
US5733329A (en) | 1996-12-30 | 1998-03-31 | Target Therapeutics, Inc. | Vaso-occlusive coil with conical end |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
GB9703859D0 (en) | 1997-02-25 | 1997-04-16 | Plante Sylvain | Expandable intravascular stent |
US6152944A (en) | 1997-03-05 | 2000-11-28 | Scimed Life Systems, Inc. | Catheter with removable balloon protector and stent delivery system with removable stent protector |
US5902475A (en) | 1997-04-08 | 1999-05-11 | Interventional Technologies, Inc. | Method for manufacturing a stent |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
WO1998047447A1 (en) | 1997-04-23 | 1998-10-29 | Dubrul William R | Bifurcated stent and distal protection system |
US5836966A (en) | 1997-05-22 | 1998-11-17 | Scimed Life Systems, Inc. | Variable expansion force stent |
FR2764794B1 (en) | 1997-06-20 | 1999-11-12 | Nycomed Lab Sa | EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS |
US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US7569066B2 (en) | 1997-07-10 | 2009-08-04 | Boston Scientific Scimed, Inc. | Methods and devices for the treatment of aneurysms |
US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
GB9715241D0 (en) | 1997-07-18 | 1997-09-24 | Jeffree Martin A | Device for treating aneurysms |
US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
WO1999011191A1 (en) | 1997-08-28 | 1999-03-11 | Boston Scientific Corporation | System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber |
US6538026B1 (en) | 1997-09-11 | 2003-03-25 | Provasis Therapeutics, Inc. | Compositions useful for remodeling body spaces |
US6074407A (en) | 1997-10-14 | 2000-06-13 | Target Therapeutics, Inc. | Delivery catheter for occlusive implants |
US6146373A (en) | 1997-10-17 | 2000-11-14 | Micro Therapeutics, Inc. | Catheter system and method for injection of a liquid embolic composition and a solidification agent |
US6511468B1 (en) | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
WO1999026559A1 (en) | 1997-11-25 | 1999-06-03 | Triad Vascular Systems, Inc. | Layered endovascular graft |
US6159165A (en) | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US5957975A (en) | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
US6036720A (en) | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US6190406B1 (en) | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US5873907A (en) | 1998-01-27 | 1999-02-23 | Endotex Interventional Systems, Inc. | Electrolytic stent delivery system and methods of use |
WO1999044538A1 (en) | 1998-01-27 | 1999-09-10 | The Regents Of The University Of California | Biodegradable polymer/protein based coils for intralumenal implants |
US20070093889A1 (en) | 1999-01-27 | 2007-04-26 | Wu Benjamin M | Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy |
US6395019B2 (en) | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
US6395018B1 (en) | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
US5935145A (en) | 1998-02-13 | 1999-08-10 | Target Therapeutics, Inc. | Vaso-occlusive device with attached polymeric materials |
US5941888A (en) | 1998-02-18 | 1999-08-24 | Target Therapeutics, Inc. | Vaso-occlusive member assembly with multiple detaching points |
US6077260A (en) | 1998-02-19 | 2000-06-20 | Target Therapeutics, Inc. | Assembly containing an electrolytically severable joint for endovascular embolic devices |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6179868B1 (en) | 1998-03-27 | 2001-01-30 | Janet Burpee | Stent with reduced shortening |
US6096021A (en) | 1998-03-30 | 2000-08-01 | The University Of Virginia Patent Foundation | Flow arrest, double balloon technique for occluding aneurysms or blood vessels |
US6063111A (en) | 1998-03-31 | 2000-05-16 | Cordis Corporation | Stent aneurysm treatment system and method |
US6015424A (en) | 1998-04-28 | 2000-01-18 | Microvention, Inc. | Apparatus and method for vascular embolization |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US6497722B1 (en) | 1998-05-04 | 2002-12-24 | Jomed Gmbh | Methods and apparatus for in-vivo tailored stents indicated for use in tortuous anatomy |
US6463317B1 (en) | 1998-05-19 | 2002-10-08 | Regents Of The University Of Minnesota | Device and method for the endovascular treatment of aneurysms |
US6099559A (en) | 1998-05-28 | 2000-08-08 | Medtronic Ave, Inc. | Endoluminal support assembly with capped ends |
US6015433A (en) | 1998-05-29 | 2000-01-18 | Micro Therapeutics, Inc. | Rolled stent with waveform perforation pattern |
WO1999062432A1 (en) | 1998-06-04 | 1999-12-09 | New York University | Endovascular thin film devices and methods for treating and preventing stroke |
US6139564A (en) | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
US5935148A (en) | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6165193A (en) | 1998-07-06 | 2000-12-26 | Microvention, Inc. | Vascular embolization with an expansible implant |
US6136011A (en) | 1998-07-14 | 2000-10-24 | Advanced Cardiovascular Systems, Inc. | Stent delivery system and method of use |
US6096175A (en) | 1998-07-17 | 2000-08-01 | Micro Therapeutics, Inc. | Thin film stent |
US6656218B1 (en) | 1998-07-24 | 2003-12-02 | Micrus Corporation | Intravascular flow modifier and reinforcement device |
US6093199A (en) | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US6818018B1 (en) | 1998-08-14 | 2004-11-16 | Incept Llc | In situ polymerizable hydrogels |
US7410482B2 (en) | 1998-09-04 | 2008-08-12 | Boston Scientific-Scimed, Inc. | Detachable aneurysm neck bridge |
AU5905599A (en) | 1998-09-04 | 2000-03-27 | Boston Scientific Limited | Detachable aneurysm neck closure patch |
US8016852B2 (en) | 1998-11-10 | 2011-09-13 | Stryker Corporation | Bioactive components for incorporation with vaso-occlusive members |
EP1051116B8 (en) | 1998-12-01 | 2009-06-10 | Washington University | Embolization device |
US6558414B2 (en) | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
US6398803B1 (en) | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US6231597B1 (en) | 1999-02-16 | 2001-05-15 | Mark E. Deem | Apparatus and methods for selectively stenting a portion of a vessel wall |
US6248122B1 (en) | 1999-02-26 | 2001-06-19 | Vascular Architects, Inc. | Catheter with controlled release endoluminal prosthesis |
US6221066B1 (en) | 1999-03-09 | 2001-04-24 | Micrus Corporation | Shape memory segmented detachable coil |
US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6428558B1 (en) | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US6273910B1 (en) | 1999-03-11 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
EP1173110B1 (en) | 1999-04-15 | 2009-07-08 | Smart Therapeutics, Inc. | Intravascular stent for treating neurovascular vessel lesion |
US6258117B1 (en) | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6899730B1 (en) | 1999-04-15 | 2005-05-31 | Scimed Life Systems, Inc. | Catheter-stent device |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6673103B1 (en) | 1999-05-20 | 2004-01-06 | Scimed Life Systems, Inc. | Mesh and stent for increased flexibility |
JP2003500106A (en) | 1999-05-21 | 2003-01-07 | マイクロ・セラピューティクス・インコーポレーテッド | Method for delivering uniformly dispersed high viscosity embolic compositions in vivo |
US20020169473A1 (en) | 1999-06-02 | 2002-11-14 | Concentric Medical, Inc. | Devices and methods for treating vascular malformations |
US6375668B1 (en) | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6280457B1 (en) | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
US6569193B1 (en) | 1999-07-22 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Tapered self-expanding stent |
US6312421B1 (en) | 1999-07-23 | 2001-11-06 | Neurovasx, Inc. | Aneurysm embolization material and device |
US6309367B1 (en) | 1999-07-23 | 2001-10-30 | Neurovasx, Inc. | Aneurysm shield |
CN1409622A (en) | 1999-09-23 | 2003-04-09 | 先进扩张技术公司 | Bifurcation stent system and method |
US6238403B1 (en) | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6602261B2 (en) | 1999-10-04 | 2003-08-05 | Microvention, Inc. | Filamentous embolic device with expansile elements |
US8048104B2 (en) | 2000-10-30 | 2011-11-01 | Dendron Gmbh | Device for the implantation of occlusion spirals |
US6428569B1 (en) | 1999-11-09 | 2002-08-06 | Scimed Life Systems Inc. | Micro structure stent configurations |
US7226475B2 (en) | 1999-11-09 | 2007-06-05 | Boston Scientific Scimed, Inc. | Stent with variable properties |
US6471672B1 (en) | 1999-11-10 | 2002-10-29 | Scimed Life Systems | Selective high pressure dilation balloon |
US6585758B1 (en) | 1999-11-16 | 2003-07-01 | Scimed Life Systems, Inc. | Multi-section filamentary endoluminal stent |
US6537310B1 (en) | 1999-11-19 | 2003-03-25 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal implantable devices and method of making same |
US6331184B1 (en) | 1999-12-10 | 2001-12-18 | Scimed Life Systems, Inc. | Detachable covering for an implantable medical device |
US6350270B1 (en) | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US6312463B1 (en) | 2000-02-01 | 2001-11-06 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
US6346117B1 (en) | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6929658B1 (en) | 2000-03-09 | 2005-08-16 | Design & Performance-Cyprus Limited | Stent with cover connectors |
US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
US6315708B1 (en) | 2000-03-31 | 2001-11-13 | Cordis Corporation | Stent with self-expanding end sections |
US20030114918A1 (en) | 2000-04-28 | 2003-06-19 | Garrison Michi E. | Stent graft assembly and method |
US6652576B1 (en) | 2000-06-07 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Variable stiffness stent |
US7052510B1 (en) | 2000-06-14 | 2006-05-30 | Medinol, Ltd. | Two Balloon staged stent expansion |
US7153323B1 (en) | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
US6855154B2 (en) | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
US6969401B1 (en) | 2000-08-18 | 2005-11-29 | Marotta Thomas R | Endovascular prosthesis |
AU2001286731A1 (en) | 2000-08-25 | 2002-03-04 | Kensey Nash Corporation | Covered stents, systems for deploying covered stents |
US8313504B2 (en) | 2000-09-18 | 2012-11-20 | Cordis Corporation | Foam matrix embolization device |
US6723108B1 (en) | 2000-09-18 | 2004-04-20 | Cordis Neurovascular, Inc | Foam matrix embolization device |
US8070792B2 (en) | 2000-09-22 | 2011-12-06 | Boston Scientific Scimed, Inc. | Stent |
US6605101B1 (en) | 2000-09-26 | 2003-08-12 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
US7033374B2 (en) | 2000-09-26 | 2006-04-25 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
US7029486B2 (en) | 2000-09-26 | 2006-04-18 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
JP4817088B2 (en) | 2000-10-10 | 2011-11-16 | 株式会社林原生物化学研究所 | Embolization material |
CA2409104A1 (en) | 2000-10-11 | 2002-04-18 | Micro Therapeutics, Inc. | Methods for treating aneurysms |
US7037330B1 (en) | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
US6814754B2 (en) | 2000-10-30 | 2004-11-09 | Secant Medical, Llc | Woven tubular graft with regions of varying flexibility |
JP4532070B2 (en) | 2000-11-17 | 2010-08-25 | エビーシオ・メディカル・デバイセズ・ユーエルシー | Endovascular prosthesis |
US7306598B2 (en) | 2000-11-24 | 2007-12-11 | Dfine, Inc. | Polymer matrix devices for treatment of vascular malformations |
US6958061B2 (en) | 2000-11-24 | 2005-10-25 | Csaba Truckai | Microspheres with sacrificial coatings for vaso-occlusive systems |
BE1013757A6 (en) | 2000-12-12 | 2002-07-02 | Frid Noureddine | Luminal endoprosthesis MODULAR. |
CA2432033A1 (en) | 2000-12-15 | 2002-06-20 | Donald R. Ricci | Endovascular prosthesis delivery system |
US6547804B2 (en) | 2000-12-27 | 2003-04-15 | Scimed Life Systems, Inc. | Selectively permeable highly distensible occlusion balloon |
US20020082620A1 (en) | 2000-12-27 | 2002-06-27 | Elaine Lee | Bioactive materials for aneurysm repair |
US6603994B2 (en) | 2000-12-28 | 2003-08-05 | Scimed Life Systems, Inc. | Apparatus and method for internally inducing a magnetic field in an aneurysm to embolize aneurysm with magnetically-controllable substance |
US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
AU2002252307B2 (en) | 2001-03-13 | 2007-07-05 | Medinol, Ltd. | Method and apparatus for stenting |
US7294137B2 (en) | 2001-03-27 | 2007-11-13 | Boston Scientific Scimed | Device for multi-modal treatment of vascular lesions |
US6585753B2 (en) | 2001-03-28 | 2003-07-01 | Scimed Life Systems, Inc. | Expandable coil stent |
EP1258230A3 (en) | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
US6602269B2 (en) | 2001-03-30 | 2003-08-05 | Scimed Life Systems | Embolic devices capable of in-situ reinforcement |
DE10118017B4 (en) | 2001-04-10 | 2017-04-13 | Dendron Gmbh | Occlusion coil and device for implantation of occlusion coils |
US6855153B2 (en) | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
EP1401338B1 (en) | 2001-05-29 | 2011-07-20 | Microvention, Inc. | Method of manufacturing expansile filamentous embolization devices |
US6692510B2 (en) | 2001-06-14 | 2004-02-17 | Cordis Neurovascular, Inc. | Aneurysm embolization device and deployment system |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US20030181927A1 (en) | 2001-06-21 | 2003-09-25 | Wallace Michael P. | Aneurysm neck obstruction device |
US20030100945A1 (en) | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US6605056B2 (en) | 2001-07-11 | 2003-08-12 | Scimed Life Systems, Inc. | Conformable balloon |
US20030014075A1 (en) | 2001-07-16 | 2003-01-16 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation |
CA2452953A1 (en) | 2001-07-18 | 2003-01-30 | The Research Foundation Of State University Of New York | Stent vascular intervention device and method |
US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US7547321B2 (en) | 2001-07-26 | 2009-06-16 | Alveolus Inc. | Removable stent and method of using the same |
US20030028209A1 (en) | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
ES2319621T3 (en) | 2001-08-23 | 2009-05-11 | Darrell C. Gumm | ROTARY SYSTEM OF IMPLANT OF ENDOVASCULAR PROTESIS FOR ACCSO OF SIDE BRANCH AND PROTECTION. |
US20030045923A1 (en) | 2001-08-31 | 2003-03-06 | Mehran Bashiri | Hybrid balloon expandable/self expanding stent |
US6811560B2 (en) | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
US6802851B2 (en) | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
US6752825B2 (en) | 2001-10-02 | 2004-06-22 | Scimed Life Systems, Inc | Nested stent apparatus |
US20030093111A1 (en) | 2001-10-26 | 2003-05-15 | Concentric Medical | Device for vaso-occlusion and interventional therapy |
JP4429589B2 (en) | 2001-11-15 | 2010-03-10 | コーディス・ニューロバスキュラー・インコーポレイテッド | Aneurysm embolization device using an occluding member |
JP2003190175A (en) | 2001-11-15 | 2003-07-08 | Cordis Neurovascular Inc | Aneurysm neck cover for sealing aneurysm |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
WO2003049600A2 (en) * | 2001-12-06 | 2003-06-19 | Stx Medical, Inc. | Medical device |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
CA2468951A1 (en) | 2001-12-20 | 2003-07-03 | Trivascular, Inc. | Advanced endovascular graft |
JP2005514985A (en) | 2002-01-14 | 2005-05-26 | マイクロ セラピューティクス, インコーポレイテッド | Method for embolizing an aneurysm site using a high viscosity embolic composition |
US7695488B2 (en) | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
US7094369B2 (en) | 2002-03-29 | 2006-08-22 | Scimed Life Systems, Inc. | Processes for manufacturing polymeric microspheres |
US20030195553A1 (en) | 2002-04-12 | 2003-10-16 | Scimed Life Systems, Inc. | System and method for retaining vaso-occlusive devices within an aneurysm |
US7195648B2 (en) | 2002-05-16 | 2007-03-27 | Cordis Neurovascular, Inc. | Intravascular stent device |
US7771387B2 (en) | 2002-05-17 | 2010-08-10 | Boston Scientific Scimed, Inc. | Liquid embolic composition delivery devices and methods |
US7060083B2 (en) | 2002-05-20 | 2006-06-13 | Boston Scientific Scimed, Inc. | Foldable vaso-occlusive member |
US7338511B2 (en) | 2002-05-24 | 2008-03-04 | Boston Scientific-Scimed, Inc. | Solid embolic material with variable expansion |
US7803179B2 (en) | 2002-05-30 | 2010-09-28 | Abbott Vascular Solutions Inc. | Intravascular stents |
US6833003B2 (en) | 2002-06-24 | 2004-12-21 | Cordis Neurovascular | Expandable stent and delivery system |
US20040002752A1 (en) | 2002-06-26 | 2004-01-01 | Scimed Life Systems, Inc. | Sacrificial anode stent system |
US7485122B2 (en) | 2002-06-27 | 2009-02-03 | Boston Scientific Scimed, Inc. | Integrated anchor coil in stretch-resistant vaso-occlusive coils |
CN101919722A (en) | 2002-07-31 | 2010-12-22 | 微温森公司 | The vascular occluding device of three-part coaxial |
US20050171572A1 (en) | 2002-07-31 | 2005-08-04 | Microvention, Inc. | Multi-layer coaxial vaso-occlusive device |
US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
US7842377B2 (en) | 2003-08-08 | 2010-11-30 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US7449236B2 (en) | 2002-08-09 | 2008-11-11 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US20040034386A1 (en) | 2002-08-19 | 2004-02-19 | Michael Fulton | Aneurysm stent |
US20040044391A1 (en) | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
US8075585B2 (en) | 2002-08-29 | 2011-12-13 | Stryker Corporation | Device and method for treatment of a vascular defect |
US20130090721A1 (en) | 2010-06-11 | 2013-04-11 | C. R. Bard, Inc. | Highly Flexible Stent and Method of Manufacture |
US7001422B2 (en) | 2002-09-23 | 2006-02-21 | Cordis Neurovascular, Inc | Expandable stent and delivery system |
EP1549248A4 (en) | 2002-09-26 | 2015-11-25 | Advanced Bio Prosthetic Surfac | High strength vacuum deposited nitionol alloy films, medical thin film graft materials and method of making same |
US7300459B2 (en) | 2002-10-17 | 2007-11-27 | Heuser Richard R | Stent with covering and differential dilation |
US6994721B2 (en) | 2002-10-21 | 2006-02-07 | Israel Henry M | Stent assembly |
US7588825B2 (en) | 2002-10-23 | 2009-09-15 | Boston Scientific Scimed, Inc. | Embolic compositions |
US7481821B2 (en) | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US20040111112A1 (en) | 2002-11-20 | 2004-06-10 | Hoffmann Gerard Von | Method and apparatus for retaining embolic material |
US6923829B2 (en) | 2002-11-25 | 2005-08-02 | Advanced Bio Prosthetic Surfaces, Ltd. | Implantable expandable medical devices having regions of differential mechanical properties and methods of making same |
US20040115164A1 (en) | 2002-12-17 | 2004-06-17 | Pierce Ryan K. | Soft filament occlusive device delivery system |
US20050165469A1 (en) | 2002-12-24 | 2005-07-28 | Michael Hogendijk | Vascular prosthesis including torsional stabilizer and methods of use |
US7229454B2 (en) | 2003-01-07 | 2007-06-12 | Boston Scientific Scimed, Inc. | Occlusive cinching devices and methods of use |
US20040193246A1 (en) | 2003-03-25 | 2004-09-30 | Microvention, Inc. | Methods and apparatus for treating aneurysms and other vascular defects |
US7182744B2 (en) | 2003-04-25 | 2007-02-27 | Medtronic Vascular | Method and apparatus for aneurismal treatment |
US7438721B2 (en) | 2003-04-25 | 2008-10-21 | Medtronic Vascular, Inc. | Universal modular stent graft assembly to accommodate flow to collateral branches |
US7112216B2 (en) | 2003-05-28 | 2006-09-26 | Boston Scientific Scimed, Inc. | Stent with tapered flexibility |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US20040260384A1 (en) | 2003-06-17 | 2004-12-23 | Medtronic Ave | Superelastic coiled stent |
US20050015110A1 (en) | 2003-07-18 | 2005-01-20 | Fogarty Thomas J. | Embolization device and a method of using the same |
US7976823B2 (en) | 2003-08-29 | 2011-07-12 | Boston Scientific Scimed, Inc. | Ferromagnetic particles and methods |
US20050209674A1 (en) | 2003-09-05 | 2005-09-22 | Kutscher Tuvia D | Balloon assembly (V) |
US20050119687A1 (en) | 2003-09-08 | 2005-06-02 | Dacey Ralph G.Jr. | Methods of, and materials for, treating vascular defects with magnetically controllable hydrogels |
US7235083B1 (en) | 2003-09-10 | 2007-06-26 | Endovascular Technologies, Inc. | Methods and devices for aiding in situ assembly of repair devices |
CN101094622A (en) | 2003-09-18 | 2007-12-26 | 先进生物假体表面有限公司 | Medical devices having mems functionality and methods of making same |
US20050065592A1 (en) | 2003-09-23 | 2005-03-24 | Asher Holzer | System and method of aneurism monitoring and treatment |
US7122052B2 (en) | 2003-09-29 | 2006-10-17 | Stout Medical Group Lp | Integral support stent graft assembly |
US8133256B2 (en) | 2003-10-02 | 2012-03-13 | Lawrence Livermore National Security, Llc | Shape memory polymer foams for endovascular therapies |
US20070135907A1 (en) | 2003-10-02 | 2007-06-14 | The Regents Of The University Of California | Stent with expandable foam |
WO2005034809A1 (en) | 2003-10-10 | 2005-04-21 | William A. Cook Australia Pty. Ltd. | Stent graft fenestration |
WO2005034808A1 (en) | 2003-10-10 | 2005-04-21 | William A. Cook Australia Pty. Ltd. | Fenestrated stent grafts |
US20050090888A1 (en) | 2003-10-28 | 2005-04-28 | Hines Richard A. | Pleated stent assembly |
US20050096725A1 (en) | 2003-10-29 | 2005-05-05 | Pomeranz Mark L. | Expandable stent having removable slat members |
US7232461B2 (en) | 2003-10-29 | 2007-06-19 | Cordis Neurovascular, Inc. | Neck covering device for an aneurysm |
US7901770B2 (en) | 2003-11-04 | 2011-03-08 | Boston Scientific Scimed, Inc. | Embolic compositions |
US9974674B2 (en) | 2003-11-08 | 2018-05-22 | Cook Medical Technologies Llc | Branch vessel prothesis with positional indicator system and method |
US20050133046A1 (en) | 2003-12-17 | 2005-06-23 | Becker Timothy A. | Compositions and methods for improved occlusion of vascular defects |
US7294123B2 (en) | 2003-12-17 | 2007-11-13 | Corris Neurovascular, Inc. | Activatable bioactive vascular occlusive device and method of use |
US7763011B2 (en) | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
DE102004003265A1 (en) | 2004-01-21 | 2005-08-11 | Dendron Gmbh | Device for the implantation of electrically isolated occlusion coils |
US8012192B2 (en) | 2004-02-18 | 2011-09-06 | Boston Scientific Scimed, Inc. | Multi-stent delivery system |
US7485123B2 (en) | 2004-03-01 | 2009-02-03 | Boston Scientific Scimed, Inc. | Complex vaso-occlusive coils |
US7488332B2 (en) | 2004-03-01 | 2009-02-10 | Boston Scientific Scimed, Inc. | Vaso-occlusive coils with non-overlapping sections |
US7736671B2 (en) | 2004-03-02 | 2010-06-15 | Boston Scientific Scimed, Inc. | Embolization |
US7901447B2 (en) | 2004-12-29 | 2011-03-08 | Boston Scientific Scimed, Inc. | Medical devices including a metallic film and at least one filament |
WO2005087114A1 (en) | 2004-03-10 | 2005-09-22 | Philips Intellectual Property & Standards Gmbh | Catheter, apparatus and method for therapeutic embolization |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US20050228434A1 (en) | 2004-03-19 | 2005-10-13 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
US8048140B2 (en) | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US7247159B2 (en) | 2004-04-08 | 2007-07-24 | Cordis Neurovascular, Inc. | Activatable bioactive vascular occlusive device |
US8024036B2 (en) | 2007-03-19 | 2011-09-20 | The Invention Science Fund I, Llc | Lumen-traveling biological interface device and method of use |
US8512219B2 (en) | 2004-04-19 | 2013-08-20 | The Invention Science Fund I, Llc | Bioelectromagnetic interface system |
US8412348B2 (en) | 2004-05-06 | 2013-04-02 | Boston Scientific Neuromodulation Corporation | Intravascular self-anchoring integrated tubular electrode body |
US7758892B1 (en) | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
ES2357243T3 (en) | 2004-05-21 | 2011-04-20 | Micro Therapeutics, Inc. | METAL SPIRALS INTERLATED WITH POLYMERS OR BIOLOGICAL OR BIODEGRADABLE OR SYNTHETIC FIBERS FOR THE EMBOLIZATION OF A BODY CAVITY. |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
JP2008502378A (en) | 2004-05-25 | 2008-01-31 | チェストナット メディカル テクノロジーズ インコーポレイテッド | Flexible vascular closure device |
US8628564B2 (en) | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US20050267510A1 (en) | 2004-05-26 | 2005-12-01 | Nasser Razack | Device for the endovascular treatment of intracranial aneurysms |
US7311861B2 (en) | 2004-06-01 | 2007-12-25 | Boston Scientific Scimed, Inc. | Embolization |
US20050277978A1 (en) | 2004-06-09 | 2005-12-15 | Secant Medical, Llc | Three-dimensional coils for treatment of vascular aneurysms |
WO2005122962A1 (en) | 2004-06-15 | 2005-12-29 | Cook Incorporated | Stent graft with internal tube |
US7749242B2 (en) | 2004-06-21 | 2010-07-06 | Boston Scientific Scimed, Inc. | Expanding vaso-occlusive device |
US20050283220A1 (en) | 2004-06-22 | 2005-12-22 | Gobran Riad H | Blood flow diverters for the treatment of intracranial aneurysms |
US7744641B2 (en) | 2004-07-21 | 2010-06-29 | Boston Scientific Scimed, Inc. | Expandable framework with overlapping connectors |
US7651525B2 (en) | 2004-08-05 | 2010-01-26 | Medtronic Vascular, Inc. | Intraluminal stent assembly and method of deploying the same |
US20060079923A1 (en) | 2004-08-09 | 2006-04-13 | Manik Chhabra | Aneurysm treatment using semi-compliant balloon |
US9051411B2 (en) | 2004-08-16 | 2015-06-09 | Lawrence Livermore National Security, Llc | Shape memory polymers |
US20060036045A1 (en) | 2004-08-16 | 2006-02-16 | The Regents Of The University Of California | Shape memory polymers |
EP1827250B1 (en) | 2004-08-31 | 2018-05-16 | Cook Medical Technologies LLC | Device for treating an aneurysm |
EP1788956B1 (en) | 2004-09-17 | 2011-11-09 | Codman & Shurtleff, Inc. | Vascular occlusion device with an embolic mesh ribbon |
US20080004653A1 (en) | 2004-09-17 | 2008-01-03 | Sherman Darren R | Thin Film Devices for Occlusion of a Vessel |
WO2006034153A2 (en) | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Thin film metallic devices for plugging aneurysms or vessels |
EP1788978B1 (en) | 2004-09-17 | 2011-11-09 | Codman & Shurtleff, Inc. | Thin film devices for temporary or permanent occlusion of a vessel |
ATE448737T1 (en) | 2004-09-22 | 2009-12-15 | Dendron Gmbh | DEVICE FOR IMPLANTING MICROWL COILS |
US8226706B2 (en) | 2004-09-22 | 2012-07-24 | Cook Medical Technologies Llc | Stent graft with integral side arm |
US7879064B2 (en) | 2004-09-22 | 2011-02-01 | Micro Therapeutics, Inc. | Medical implant |
EP1799126B1 (en) | 2004-10-15 | 2011-12-07 | Codman & Shurtleff, Inc. | Remodeling device for aneurysms |
CA2622893A1 (en) | 2004-10-26 | 2006-05-04 | Medical College Of Georgia Research Institute | Devices and methods for aneurysm treatment |
WO2006047748A2 (en) | 2004-10-26 | 2006-05-04 | Cordis Neurovascular, Inc. | Method of delivering embolic particles to an aneurysm |
US7147659B2 (en) | 2004-10-28 | 2006-12-12 | Cordis Neurovascular, Inc. | Expandable stent having a dissolvable portion |
US7156871B2 (en) | 2004-10-28 | 2007-01-02 | Cordis Neurovascular, Inc. | Expandable stent having a stabilized portion |
US8388677B2 (en) | 2004-10-29 | 2013-03-05 | Boston Scientific Scimed, Inc. | Anti-thrombogenic and anti-restenotic vascular medical devices |
US8308794B2 (en) | 2004-11-15 | 2012-11-13 | IZEK Technologies, Inc. | Instrumented implantable stents, vascular grafts and other medical devices |
US8771294B2 (en) | 2004-11-26 | 2014-07-08 | Biomerix Corporation | Aneurysm treatment devices and methods |
US20090297582A1 (en) | 2004-11-26 | 2009-12-03 | Biomerix Corporation | Vascular occlusion devices and methods |
US20060116713A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US20060116709A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US8292944B2 (en) | 2004-12-17 | 2012-10-23 | Reva Medical, Inc. | Slide-and-lock stent |
US20060136033A1 (en) | 2004-12-20 | 2006-06-22 | Vascular Architects, Inc. | Coiled stent delivery system and method |
US7722529B2 (en) | 2004-12-28 | 2010-05-25 | Palo Alto Investors | Expandable vessel harness for treating vessel aneurysms |
US7857843B2 (en) | 2004-12-31 | 2010-12-28 | Boston Scientific Scimed, Inc. | Differentially expanded vascular graft |
US20060155367A1 (en) * | 2005-01-07 | 2006-07-13 | Hines Richard A | Micro-pleated stent assembly |
US20060155323A1 (en) | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
US8287583B2 (en) | 2005-01-10 | 2012-10-16 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
US20110054511A1 (en) | 2005-01-26 | 2011-03-03 | Micrus Endovascular Corporation | Adding microscopic porosity to the surface of a microcoil to be used for medical implantation |
MX2007008923A (en) | 2005-01-26 | 2008-02-21 | Micrus Endovascular Corp | Implantable microcoil with microscopic porosity surface. |
US20060178696A1 (en) | 2005-02-04 | 2006-08-10 | Porter Stephen C | Macroporous materials for use in aneurysms |
US7344544B2 (en) | 2005-03-28 | 2008-03-18 | Cardica, Inc. | Vascular closure system |
JP5523700B2 (en) | 2005-04-04 | 2014-06-18 | フレキシブル ステンティング ソリューションズ,インク. | Flexible stent |
DE102005019782A1 (en) | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
AU2005332044B2 (en) | 2005-05-25 | 2012-01-19 | Covidien Lp | System and method for delivering and deploying and occluding device within a vessel |
US8002789B2 (en) | 2005-05-31 | 2011-08-23 | Stryker Corporation | Stretch-resistant vaso-occlusive devices with flexible detachment junctions |
US7708755B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff Inc. | Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism |
US7819891B2 (en) | 2005-06-02 | 2010-10-26 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil delivery system with spring release mechanism |
US7819892B2 (en) | 2005-06-02 | 2010-10-26 | Codman & Shurtleff, Inc. | Embolic coil delivery system with spring wire release mechanism |
US7799052B2 (en) | 2005-06-02 | 2010-09-21 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7985238B2 (en) | 2005-06-02 | 2011-07-26 | Codman & Shurtleff, Inc. | Embolic coil delivery system with spring wire release mechanism |
US7708754B2 (en) | 2005-06-02 | 2010-05-04 | Codman & Shurtleff, Pc | Stretch resistant embolic coil delivery system with mechanical release mechanism |
US7811305B2 (en) | 2005-06-02 | 2010-10-12 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil delivery system with spring release mechanism |
AU2006269419A1 (en) | 2005-07-07 | 2007-01-18 | Nellix, Inc. | Systems and methods for endovascular aneurysm treatment |
US20070021816A1 (en) | 2005-07-21 | 2007-01-25 | The Research Foundation Of State University Of New York | Stent vascular intervention device and methods for treating aneurysms |
US7850810B2 (en) | 2005-07-29 | 2010-12-14 | Gore Enterprise Holdings, Inc. | Method of making porous self-cohered web materials |
US20070027551A1 (en) | 2005-07-29 | 2007-02-01 | Farnsworth Ted R | Composite self-cohered web materials |
US7604668B2 (en) | 2005-07-29 | 2009-10-20 | Gore Enterprise Holdings, Inc. | Composite self-cohered web materials |
US7914574B2 (en) | 2005-08-02 | 2011-03-29 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
AU2006280948B2 (en) | 2005-08-18 | 2011-10-27 | Cook Incorporated | Assembly of stent grafts |
US8038706B2 (en) | 2005-09-08 | 2011-10-18 | Boston Scientific Scimed, Inc. | Crown stent assembly |
US20070060994A1 (en) | 2005-09-12 | 2007-03-15 | Gobran Riad H | Blood flow diverters for the treatment of intracranial aneurysms |
US8057495B2 (en) | 2005-09-13 | 2011-11-15 | Cook Medical Technologies Llc | Aneurysm occlusion device |
US8956400B2 (en) | 2005-10-14 | 2015-02-17 | Flexible Stenting Solutions, Inc. | Helical stent |
US8545530B2 (en) | 2005-10-19 | 2013-10-01 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
WO2007051179A2 (en) | 2005-10-27 | 2007-05-03 | Nfocus Neuromedical Inc. | Partially covered stent devices and methods of use |
US7776079B2 (en) | 2005-10-31 | 2010-08-17 | Boston Scientific Scimed, Inc. | Conical balloon for deployment into side branch |
US7404823B2 (en) | 2005-10-31 | 2008-07-29 | Boston Scientific Scimed, Inc. | Stent configurations |
WO2007055654A1 (en) | 2005-11-09 | 2007-05-18 | Merlin Md Pte Ltd | Medical device with non-circumferential surface portion |
WO2007076179A2 (en) | 2005-11-17 | 2007-07-05 | Microvention, Inc. | Three-dimensional complex coil |
US7540881B2 (en) | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US20070150041A1 (en) | 2005-12-22 | 2007-06-28 | Nellix, Inc. | Methods and systems for aneurysm treatment using filling structures |
US7744652B2 (en) | 2006-01-23 | 2010-06-29 | Hesham Morsi | Aneurysm sealing device |
WO2007090127A2 (en) | 2006-01-30 | 2007-08-09 | Surgica Corporation | Compressible intravascular embolization particles and related methods and delivery systems |
US7691124B2 (en) | 2006-01-31 | 2010-04-06 | Codman & Shurtleff, Inc. | Delivery of therapeutic devices |
WO2007088549A2 (en) | 2006-02-03 | 2007-08-09 | Design & Performance - Cyprus Limited | Implantable graft assembly and aneurysm treatment |
US8784477B2 (en) | 2011-01-05 | 2014-07-22 | Abbott Cardiovascular Systems Inc. | Stent graft with two layer ePTFE layer system with high plasticity and high rigidity |
US8585753B2 (en) | 2006-03-04 | 2013-11-19 | John James Scanlon | Fibrillated biodegradable prosthesis |
EP2004270B1 (en) | 2006-03-14 | 2016-11-02 | Thermopeutix Inc. | Aneurysm coil delivery system |
US20070219610A1 (en) | 2006-03-20 | 2007-09-20 | Israel Henry M | Stent with flap |
US20090318941A1 (en) | 2006-03-24 | 2009-12-24 | Biomerix Corporation | Self-Expandable Endovascular Device For Aneurysm Occlusion |
US7766933B2 (en) | 2006-03-31 | 2010-08-03 | Codman & Shurtleff, Inc. | Stretch resistant design for embolic coils with stabilization bead |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
JP5061181B2 (en) | 2006-04-07 | 2012-10-31 | ピナンブラ、インク | System and method for occluding an aneurysm |
CN101500623B (en) | 2006-06-15 | 2016-08-24 | 微温森公司 | A kind of embolization device being made up of expandable polymer |
US8478437B2 (en) | 2006-06-16 | 2013-07-02 | The Invention Science Fund I, Llc | Methods and systems for making a blood vessel sleeve |
US8095382B2 (en) | 2006-06-16 | 2012-01-10 | The Invention Science Fund I, Llc | Methods and systems for specifying a blood vessel sleeve |
US7818084B2 (en) | 2006-06-16 | 2010-10-19 | The Invention Science Fund, I, LLC | Methods and systems for making a blood vessel sleeve |
US8163003B2 (en) | 2006-06-16 | 2012-04-24 | The Invention Science Fund I, Llc | Active blood vessel sleeve methods and systems |
US8550344B2 (en) | 2006-06-16 | 2013-10-08 | The Invention Science Fund I, Llc | Specialty stents with flow control features or the like |
US8147537B2 (en) | 2006-06-16 | 2012-04-03 | The Invention Science Fund I, Llc | Rapid-prototyped custom-fitted blood vessel sleeve |
US8551155B2 (en) | 2006-06-16 | 2013-10-08 | The Invention Science Fund I, Llc | Stent customization system and method |
US20070299461A1 (en) | 2006-06-21 | 2007-12-27 | Boston Scientific Scimed, Inc. | Embolic coils and related components, systems, and methods |
US20080004692A1 (en) | 2006-06-28 | 2008-01-03 | Henson Michael R | Dynamically adjustable vascular stent |
WO2008013803A2 (en) | 2006-07-24 | 2008-01-31 | Massachusetts Institute Of Technology | Endovascular devices with axial perturbations |
US20080033341A1 (en) | 2006-08-04 | 2008-02-07 | Bay Holdings Ltd. | Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof |
US8460240B2 (en) | 2006-08-07 | 2013-06-11 | W. L. Gore & Associates, Inc. | Inflatable toroidal-shaped balloons |
AU2007285800A1 (en) | 2006-08-17 | 2008-02-21 | Nfocus Neuromedical, Inc. | Isolation devices for the treatment of aneurysms |
EP2056745A2 (en) | 2006-08-17 | 2009-05-13 | Nfocus Neuromedical Inc. | Aneurysm covering devices and delivery devices |
US8034073B2 (en) | 2006-08-18 | 2011-10-11 | Codman & Shurtleff, Inc. | Stretch resistant embolic coil |
US8414637B2 (en) | 2006-09-08 | 2013-04-09 | Boston Scientific Scimed, Inc. | Stent |
WO2008034047A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Endoprosthesis with adjustable surface features |
US7927348B2 (en) | 2006-10-10 | 2011-04-19 | Codman & Shurtleff, Inc. | Stretch resistant coil device |
US8257431B2 (en) | 2006-11-01 | 2012-09-04 | Boston Scientific Scimed, Inc. | Multi-furcated ePTFE grafts and stent-graft prostheses and methods of making the same |
JP2010508910A (en) | 2006-11-02 | 2010-03-25 | アール. ショーン パクバズ, | Devices and methods for accessing and treating aneurysms |
WO2008063455A1 (en) | 2006-11-13 | 2008-05-29 | Hines Richard A | Over-the wire exclusion device and system for delivery |
US8795346B2 (en) | 2006-11-20 | 2014-08-05 | Boston Scientific Scimed, Inc. | Semi rigid edge protection design for stent delivery system |
US8187315B1 (en) | 2006-12-08 | 2012-05-29 | Cardica, Inc. | Partial stent for treatment of a vascular aneurysm |
WO2008074027A1 (en) | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
US8473030B2 (en) | 2007-01-12 | 2013-06-25 | Medtronic Vascular, Inc. | Vessel position and configuration imaging apparatus and methods |
US20080177376A1 (en) | 2007-01-18 | 2008-07-24 | Medtronic Vascular, Inc. | Stent With Improved Flexibility and Method for Making Same |
EP4005537A1 (en) | 2007-02-12 | 2022-06-01 | C.R. Bard Inc. | Highly flexible stent and method of manufacture |
US8333799B2 (en) | 2007-02-12 | 2012-12-18 | C. R. Bard, Inc. | Highly flexible stent and method of manufacture |
DE102007012964A1 (en) | 2007-03-06 | 2008-09-11 | Phenox Gmbh | Implant for influencing blood flow |
US8348994B2 (en) | 2007-03-09 | 2013-01-08 | Novostent Corporation | Vascular prosthesis with alternating helical sections |
KR20100015520A (en) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant including a coil and a stretch-resistant member |
US20080249608A1 (en) | 2007-04-04 | 2008-10-09 | Vipul Dave | Bioabsorbable Polymer, Bioabsorbable Composite Stents |
US8715336B2 (en) | 2007-04-19 | 2014-05-06 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent to branch arteries |
US8425541B2 (en) | 2007-04-27 | 2013-04-23 | Wisconsin Alumni Research Foundation | Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent |
US20110022149A1 (en) | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
EP2171143B1 (en) | 2007-06-20 | 2015-10-21 | Atex Technologies, Inc. | Compressible resilient fabric, devices, and methods |
US20080319533A1 (en) | 2007-06-22 | 2008-12-25 | Neurovasx, Inc. | Aneurysm occlusion assist device |
WO2009003049A2 (en) | 2007-06-25 | 2008-12-31 | Micro Vention, Inc. | Self-expanding prosthesis |
US8048147B2 (en) | 2007-06-27 | 2011-11-01 | Aga Medical Corporation | Branched stent/graft and method of fabrication |
DE102007031796A1 (en) | 2007-07-07 | 2009-01-08 | WRW Consulting GbR (Vertretungsberechtigter Gesellschafter: Dr. Walter Reith, 66424 Homburg) | Radially expandable system for use in body tubes |
US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
WO2009020653A1 (en) | 2007-08-08 | 2009-02-12 | Cleveland Clinic Foundation | Branched stent graft system |
US8597342B2 (en) | 2007-08-24 | 2013-12-03 | Cook Medical Technologies Llc | Textile graft for in situ fenestration |
WO2009036219A1 (en) | 2007-09-11 | 2009-03-19 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
WO2009052432A2 (en) | 2007-10-19 | 2009-04-23 | Coherex Medical, Inc. | Medical device for modification of left atrial appendange and related systems and methods |
WO2009061969A2 (en) | 2007-11-06 | 2009-05-14 | Daniel Gelbart | In vivo inflatable structures, for example to expand stents |
WO2009062264A1 (en) | 2007-11-15 | 2009-05-22 | Endogad Research Pty Limited | Hybrid intraluminal device |
US7988721B2 (en) | 2007-11-30 | 2011-08-02 | Reva Medical, Inc. | Axially-radially nested expandable device |
ES2372257T3 (en) | 2007-12-14 | 2012-01-17 | Micrus Endovascular Llc | MULTIFILAMENT SPIRAL FOR INTERVENTIONAL THERAPIES. |
EP2266639B1 (en) | 2007-12-21 | 2016-10-05 | MicroVention, Inc. | Methods for preparing hydrogel filaments for biomedical use |
WO2009086269A2 (en) | 2007-12-21 | 2009-07-09 | Massachusetts Institute Of Technology | Endovascular devices/catheter platforms and methods for achieving congruency in sequentially deployed devices |
US8574284B2 (en) | 2007-12-26 | 2013-11-05 | Cook Medical Technologies Llc | Low profile non-symmetrical bare alignment stents with graft |
US9180030B2 (en) | 2007-12-26 | 2015-11-10 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
US8728145B2 (en) | 2008-12-11 | 2014-05-20 | Cook Medical Technologies Llc | Low profile non-symmetrical stents and stent-grafts |
US8992593B2 (en) | 2007-12-26 | 2015-03-31 | Cook Medical Technologies Llc | Apparatus and methods for deployment of a modular stent-graft system |
US8246672B2 (en) | 2007-12-27 | 2012-08-21 | Cook Medical Technologies Llc | Endovascular graft with separately positionable and removable frame units |
US7963987B2 (en) | 2007-12-28 | 2011-06-21 | Cook Medical Technologies Llc | Sequential implant delivery system |
US8623071B2 (en) | 2008-01-07 | 2014-01-07 | DePuy Synthes Products, LLC | Radiopaque super-elastic intravascular stent |
US20110046716A1 (en) | 2008-02-20 | 2011-02-24 | Murray Vascular Pty Limited | Stent |
US20090227976A1 (en) | 2008-03-05 | 2009-09-10 | Calabria Marie F | Multiple biocompatible polymeric strand aneurysm embolization system and method |
US20090228029A1 (en) | 2008-03-05 | 2009-09-10 | Neuro Vasx, Inc. | Aneurysm shield anchoring device |
EP2262443A2 (en) | 2008-03-10 | 2010-12-22 | NFocus Neuromedical, Inc. | Stents and stent grafts |
US8100960B2 (en) | 2008-03-20 | 2012-01-24 | Medtronic Vascular, Inc. | Bloused stent-graft and fenestration method |
US8974518B2 (en) | 2008-03-25 | 2015-03-10 | Medtronic Vascular, Inc. | Eversible branch stent-graft and deployment method |
US8257684B2 (en) | 2008-03-26 | 2012-09-04 | Neurosigma, Inc. | Methods for identifying and targeting autonomic brain regions |
EP2633823B1 (en) | 2008-04-21 | 2016-06-01 | Covidien LP | Braid-ball embolic devices and delivery systems |
WO2009132141A1 (en) | 2008-04-22 | 2009-10-29 | Coherex Medical, Inc. | Device, system and method for aneurysm embolization |
CN102083493A (en) | 2008-05-01 | 2011-06-01 | 安纽克罗斯有限责任公司 | Aneurysm occlusion device |
CN106974691A (en) | 2008-05-02 | 2017-07-25 | 斯昆特医疗公司 | Thread device for treating vascular defects |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US20090299448A1 (en) | 2008-05-30 | 2009-12-03 | Neurovasx, Inc. | Aneurysm treatment system |
AU2009256084A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
US20100016833A1 (en) | 2008-07-15 | 2010-01-21 | Ogle Matthew F | Devices for the Treatment of Vascular Aneurysm |
DE202008009604U1 (en) | 2008-07-17 | 2008-11-27 | Sahl, Harald, Dr. | Membrane implant for the treatment of cerebral artery aneurysms |
CA2731735A1 (en) | 2008-07-22 | 2010-01-28 | Microtherapeutics, Inc. | Vascular remodeling device |
WO2010016923A1 (en) | 2008-08-06 | 2010-02-11 | Boston Scientific Scimed, Inc. | Vaso-occlusive devices with textured surfaces |
US8353943B2 (en) | 2008-08-29 | 2013-01-15 | Cook Medical Technologies Llc | Variable weave graft with metal strand reinforcement for in situ fenestration |
US8388650B2 (en) | 2008-09-05 | 2013-03-05 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US20100069948A1 (en) | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
US8795347B2 (en) | 2008-09-25 | 2014-08-05 | Advanced Bifurcation Systems, Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US8769796B2 (en) | 2008-09-25 | 2014-07-08 | Advanced Bifurcation Systems, Inc. | Selective stent crimping |
CA2737753C (en) | 2008-10-10 | 2017-03-14 | Reva Medical, Inc. | Expandable slide and lock stent |
US8202292B2 (en) | 2008-10-13 | 2012-06-19 | Stryker Corporation | Vaso-occlusive coil delivery system |
US8470013B2 (en) | 2008-10-20 | 2013-06-25 | Imds Corporation | Systems and methods for aneurysm treatment and vessel occlusion |
US20100131002A1 (en) | 2008-11-24 | 2010-05-27 | Connor Robert A | Stent with a net layer to embolize and aneurysm |
US8734502B2 (en) | 2008-12-17 | 2014-05-27 | Cook Medical Technologies Llc | Tapered stent and flexible prosthesis |
EP2394610A1 (en) | 2009-02-06 | 2011-12-14 | Keio University | Stent to be used in tubular organ in vivo |
WO2010102254A2 (en) | 2009-03-06 | 2010-09-10 | The Regents Of The University Of California | Thin film vascular stent and biocompatible surface treatment |
GB2469073A (en) | 2009-03-31 | 2010-10-06 | Barking Havering And Redbridge | Balloon Assisted Occlusion of Aneurysms |
US20100268320A1 (en) | 2009-04-17 | 2010-10-21 | Medtronic Vascular, Inc. | Endovascular Implant Having an Integral Graft Component and Method of Manufacture |
WO2010123003A1 (en) | 2009-04-20 | 2010-10-28 | 株式会社カネカ | Embolization coil |
US20100274276A1 (en) | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
WO2010134914A1 (en) | 2009-05-20 | 2010-11-25 | University Of Miami | Spherical helix embolic coils for the treatment of cerebral aneurysms |
US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
US20110004294A1 (en) | 2009-07-02 | 2011-01-06 | Abbott Laboratories | Fatigue-resistant stent |
US8357179B2 (en) | 2009-07-08 | 2013-01-22 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
US8795345B2 (en) | 2009-07-08 | 2014-08-05 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
US8529596B2 (en) | 2009-07-08 | 2013-09-10 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
US20110009941A1 (en) | 2009-07-08 | 2011-01-13 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
US8357178B2 (en) | 2009-07-08 | 2013-01-22 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
US8491646B2 (en) | 2009-07-15 | 2013-07-23 | Endologix, Inc. | Stent graft |
WO2011017123A2 (en) | 2009-07-27 | 2011-02-10 | Endologix, Inc. | Stent graft |
US10420862B2 (en) | 2009-08-24 | 2019-09-24 | Aresenal AAA, LLC. | In-situ forming foams for treatment of aneurysms |
US20110054589A1 (en) | 2009-08-27 | 2011-03-03 | Boston Scientific Scimed, Inc. | Stent with variable cross section braiding filament and method for making same |
KR101788338B1 (en) | 2009-09-04 | 2017-10-19 | 펄사 배스큘라, 아이엔씨. | Systems and methods for enclosing an anatomical opening |
US9474532B2 (en) | 2009-09-09 | 2016-10-25 | Kaneka Corporation | Embolization coil |
ES2445164T3 (en) | 2009-10-06 | 2014-02-28 | Regents Of The University Of Minnesota | Bioreabsorbable embolization microspheres |
KR20110043799A (en) | 2009-10-16 | 2011-04-28 | 강호창 | Micro-coil assembly |
KR101745748B1 (en) | 2009-10-26 | 2017-06-12 | 마이크로벤션, 인코포레이티드 | Embolization device constructed from expansile polymer |
US9649211B2 (en) | 2009-11-04 | 2017-05-16 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
AU2010314994B2 (en) | 2009-11-09 | 2016-10-06 | Spotlight Technology Partners Llc | Fragmented hydrogels |
US20110202085A1 (en) | 2009-11-09 | 2011-08-18 | Siddharth Loganathan | Braid Ball Embolic Device Features |
WO2011057131A1 (en) | 2009-11-09 | 2011-05-12 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
AU2010339980C1 (en) | 2009-12-16 | 2014-07-10 | Endoshape, Inc. | Multi-fiber shape memory device |
DE102009060228B4 (en) | 2009-12-23 | 2014-12-04 | Acandis Gmbh & Co. Kg | Medical devices |
US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
US20110184454A1 (en) | 2010-01-27 | 2011-07-28 | Penumbra, Inc. | Embolic implants |
EP2351779B1 (en) | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Microspheres and method of making the microspheres |
EP2528541B1 (en) | 2010-01-28 | 2016-05-18 | Covidien LP | Vascular remodeling device |
US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
CN102933161A (en) | 2010-02-08 | 2013-02-13 | 萨帕斯医药有限公司 | Method and device for treating cerebrovascular pathologies and delivery system therefor |
KR101250443B1 (en) | 2010-02-08 | 2013-04-08 | 권오기 | Embolus forming in-vivo indwelling-coil and the makigng methods for Embolus forming in-vivo indwelling coil |
CN102188300B (en) | 2010-03-02 | 2014-05-28 | 上海微创医疗器械(集团)有限公司 | Aneurismal surgical device |
EP2365009A1 (en) | 2010-03-10 | 2011-09-14 | Universite Claude Bernard Lyon 1 (UCBL) | Radiopaque, non-biodegradable, water-insoluble iodinated benzyl ethers of poly(vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof |
WO2011119883A1 (en) | 2010-03-24 | 2011-09-29 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
US20120078285A1 (en) | 2010-04-01 | 2012-03-29 | Penumbra, Inc. | Balloon catheter for intravascular therapies |
AU2010201676B1 (en) | 2010-04-23 | 2010-07-22 | Cook Medical Technologies Llc | Curve forming stent graft |
US8702776B2 (en) | 2010-04-26 | 2014-04-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
US20110276071A1 (en) | 2010-05-08 | 2011-11-10 | Connor Robert A | Vasospasm-reducing aneurysm clip |
US8840867B2 (en) | 2010-05-20 | 2014-09-23 | Val-Chum Limited Partnership | Embolizing sclerosing hydrogel |
EP2387951B1 (en) | 2010-05-23 | 2012-12-26 | Occlutech Holding AG | Braided medical device and manufacturing method therefore |
JP5801037B2 (en) | 2010-05-25 | 2015-10-28 | アクセスポイント テクノロジーズ有限会社 | Stent |
WO2011150118A2 (en) | 2010-05-25 | 2011-12-01 | The Regents Of The University Of California | Ultra-low fractional area coverage flow diverter for treating aneurysms and vascular diseases |
US9220506B2 (en) | 2010-06-16 | 2015-12-29 | DePuy Synthes Products, Inc. | Occlusive device with stretch resistant member and anchor filament |
AU2010202544B1 (en) | 2010-06-18 | 2010-08-26 | Cook Incorporated | Side branch stent graft |
US8425548B2 (en) | 2010-07-01 | 2013-04-23 | Aneaclose LLC | Occluding member expansion and then stent expansion for aneurysm treatment |
US10265200B2 (en) | 2010-08-10 | 2019-04-23 | Cook Medical Technologies Llc | Medical prostheses having bundled and non-bundled regions |
DE102010044746A1 (en) | 2010-09-08 | 2012-03-08 | Phenox Gmbh | Implant for influencing the blood flow in arteriovenous malformations |
US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
US20130066357A1 (en) | 2010-09-10 | 2013-03-14 | Maria Aboytes | Devices and methods for the treatment of vascular defects |
EP3354210B1 (en) | 2010-09-10 | 2022-10-26 | Covidien LP | Devices for the treatment of vascular defects |
US9186149B2 (en) | 2010-10-12 | 2015-11-17 | Boston Scientific Scimed, Inc. | Vaso-occlusive device |
WO2012078678A1 (en) | 2010-12-06 | 2012-06-14 | Tyco Healthcare Group Lp | Vascular remodeling device |
US9867725B2 (en) | 2010-12-13 | 2018-01-16 | Microvention, Inc. | Stent |
JP2014507196A (en) | 2010-12-28 | 2014-03-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Stent |
JP2014508559A (en) | 2010-12-30 | 2014-04-10 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Multi-stage open stent design |
US8535590B2 (en) | 2011-01-12 | 2013-09-17 | Cook Medical Technologies Llc | Spray system and method of making phase separated polymer membrane structures |
US10166128B2 (en) | 2011-01-14 | 2019-01-01 | W. L. Gore & Associates. Inc. | Lattice |
US9839540B2 (en) | 2011-01-14 | 2017-12-12 | W. L. Gore & Associates, Inc. | Stent |
CA2824284C (en) | 2011-01-17 | 2020-10-27 | Novita Therapeutics, Llc | Ballstent device and methods of use |
US9095420B2 (en) | 2011-01-24 | 2015-08-04 | Tufts Medical Center, Inc. | Endovascular stent |
CA2826615A1 (en) | 2011-02-04 | 2012-08-09 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
EP2672932B1 (en) | 2011-02-08 | 2018-09-19 | Advanced Bifurcation Systems, Inc. | System for treating a bifurcation with a fully crimped stent |
US20130041454A1 (en) | 2011-02-09 | 2013-02-14 | Business Expectations Llc | Sensor Actuated Stent |
CN203591290U (en) | 2011-02-11 | 2014-05-14 | 斯瑞克公司 | Vascular occlusion device |
CN103442653B (en) | 2011-02-11 | 2016-06-01 | 柯惠有限合伙公司 | Two benches launches aneurysma embolization device |
WO2012112749A2 (en) | 2011-02-18 | 2012-08-23 | Sequent Medical, Inc. | Blood flow disruption devices and methods for the treatment of vascular defects |
DE102011011869A1 (en) | 2011-02-22 | 2012-08-23 | Phenox Gmbh | implant |
DE102011012501A1 (en) | 2011-02-25 | 2012-08-30 | Phenox Gmbh | Implant with fiber fleece |
WO2012118957A2 (en) | 2011-03-02 | 2012-09-07 | Eskridge Joe Michael | Endovascular closure system |
JP6078480B2 (en) | 2011-03-09 | 2017-02-08 | オカルジェル | Implantable swellable bioabsorbable polymer |
WO2012134990A1 (en) | 2011-03-25 | 2012-10-04 | Tyco Healthcare Group Lp | Vascular remodeling device |
US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
US20130190805A1 (en) | 2011-03-31 | 2013-07-25 | DePuy Synthes Products, LLC | Method of fabricating modifiable occlusion device |
US20120253377A1 (en) | 2011-03-31 | 2012-10-04 | Codman & Shurtleff, Inc. | Modifiable occlusion device |
US20130204288A1 (en) | 2011-03-31 | 2013-08-08 | DePuy Synthes Products, LLC | Modifiable occlusion device |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
US20120271399A1 (en) | 2011-04-19 | 2012-10-25 | Medtronic Vascular, Inc. | High Metal to Vessel Ratio Landing Zone Stent-Graft and Method |
EP2517671B1 (en) | 2011-04-28 | 2016-05-11 | Cook Medical Technologies LLC | Apparatus for facilitating deployment of an endoluminal prosthesis |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
EP2707078B1 (en) | 2011-05-11 | 2017-07-05 | Microvention, Inc. | Occlusion device for body cavities. |
WO2012158883A1 (en) | 2011-05-19 | 2012-11-22 | Tyco Healthcare Group Lp | Vascular remodeling device |
WO2012158881A1 (en) | 2011-05-19 | 2012-11-22 | Tyco Healthcare Group Lp | Vascular remodeling device |
US9138232B2 (en) | 2011-05-24 | 2015-09-22 | Aneuclose Llc | Aneurysm occlusion by rotational dispensation of mass |
KR101480514B1 (en) | 2011-05-26 | 2015-01-09 | 재단법인 아산사회복지재단 | Stent for cerebral aneurysm coil embolization |
KR102019025B1 (en) | 2011-06-03 | 2019-09-06 | 펄사 배스큘라, 아이엔씨. | Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices |
US9504588B2 (en) | 2011-06-05 | 2016-11-29 | The Research Foundation For The State University Of New York | System and method for simulating deployment configuration of an expandable device |
US20120316632A1 (en) | 2011-06-13 | 2012-12-13 | Bulang Gao | Retrievable covered stent for bifurcation aneurysms |
US9830427B2 (en) | 2011-06-20 | 2017-11-28 | Siemens Healthcare Gmbh | Method for intracranial aneurysm analysis and endovascular intervention planning |
US20120330341A1 (en) | 2011-06-22 | 2012-12-27 | Becking Frank P | Folded-Flat Aneurysm Embolization Devices |
AU2012203620B9 (en) | 2011-06-24 | 2014-10-02 | Cook Medical Technologies Llc | Helical Stent |
US8577693B2 (en) | 2011-07-13 | 2013-11-05 | The Invention Science Fund I, Llc | Specialty stents with flow control features or the like |
JP5665803B2 (en) | 2011-07-15 | 2015-02-04 | クック メディカル テクノロジーズ エルエルシーCook Medical Technologies Llc | Method for electrospinning a graft layer |
US8728094B2 (en) | 2011-07-19 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Percutaneous aneurysm inversion and ligation |
US9198668B2 (en) | 2011-08-04 | 2015-12-01 | Cook Medical Technologies Llc | Cerebral aneurysm closure device |
AU2012295244B2 (en) | 2011-08-12 | 2015-09-03 | W. L. Gore & Associates, Inc. | Devices and methods for approximating the cross-sectional profile of vasculature having branches |
US20130053872A1 (en) | 2011-08-23 | 2013-02-28 | Cook Medical Technologies Llc | Device and method for preventing blood flow into an aneurysm |
US11185403B2 (en) | 2011-08-31 | 2021-11-30 | Cook Medical Technologies Llc | Endoluminal prosthesis assembly |
EP2755574A1 (en) | 2011-09-13 | 2014-07-23 | Stryker Corporation | Vaso-occlusive device |
WO2013049448A1 (en) | 2011-09-29 | 2013-04-04 | Covidien Lp | Vascular remodeling device |
WO2013049837A1 (en) | 2011-09-30 | 2013-04-04 | Medicalcue, Inc. | Umbilical probe measurement systems |
US20130089576A1 (en) | 2011-10-04 | 2013-04-11 | The Texas A&M University System | Implantable embolic scaffolds that promote healing |
ES2809210T3 (en) | 2011-10-05 | 2021-03-03 | Pulsar Vascular Inc | Systems and devices for wrapping an anatomical opening |
WO2013055703A1 (en) | 2011-10-07 | 2013-04-18 | Cornell University | Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow |
US9144486B2 (en) | 2011-10-14 | 2015-09-29 | Trivascular, Inc. | Fenestrated inflatable graft |
US8936784B2 (en) | 2011-10-17 | 2015-01-20 | Poly-Med, Inc. | Absorbable in situ gel-forming system, method of making and use thereof |
US20130289690A1 (en) | 2011-11-01 | 2013-10-31 | Hira V. Thapliyal | Personalized prosthesis and methods of use |
US8771341B2 (en) | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
US9072620B2 (en) | 2011-11-04 | 2015-07-07 | Covidien Lp | Protuberant aneurysm bridging device deployment method |
CN103930154B (en) | 2011-11-09 | 2016-03-23 | 斯瑞克公司 | There is the medical treatment device of bicomponent fibre sleeve pipe |
US20130123901A1 (en) | 2011-11-14 | 2013-05-16 | Robert A. Connor | Stent with in situ determination of wall areas with differences in porosity |
EP2782521B1 (en) | 2011-11-23 | 2017-03-08 | Microvention, Inc. | Embolic device with shaped wire |
KR101315443B1 (en) | 2011-12-02 | 2013-10-07 | 강호창 | Micro-coil assembly |
US8894701B2 (en) | 2011-12-23 | 2014-11-25 | Cook Medical Technologies Llc | Hybrid balloon-expandable/self-expanding prosthesis for deployment in a body vessel and method of making |
JP2013153810A (en) | 2012-01-27 | 2013-08-15 | Terumo Corp | Knob treatment device and knob treatment method |
JP2013154089A (en) | 2012-01-31 | 2013-08-15 | Terumo Corp | Aneurysm treatment device and aneurysm treatment method |
US20130204351A1 (en) | 2012-02-02 | 2013-08-08 | Inceptus Medical LLC | Aneurysm Graft Devices And Methods |
US9113890B2 (en) | 2012-02-06 | 2015-08-25 | Aga Medical Corporation | Devices and methods for occluding vascular abnormalities |
US9107770B2 (en) | 2012-02-14 | 2015-08-18 | W. L. Gore & Associates, Inc. | Endoprosthesis with varying compressibility and methods of use |
US20130226278A1 (en) | 2012-02-23 | 2013-08-29 | Tyco Healthcare Group Lp | Methods and apparatus for luminal stenting |
US9072624B2 (en) | 2012-02-23 | 2015-07-07 | Covidien Lp | Luminal stenting |
WO2013130937A1 (en) | 2012-03-01 | 2013-09-06 | Tufts University | Endovascular silk-protein based embolization of blood vessels |
US20130245369A1 (en) | 2012-03-15 | 2013-09-19 | Sorin Crm Sas | Left atrial appendage occlusion systems |
EP2825129B2 (en) | 2012-03-16 | 2020-02-19 | Terumo Corporation | Stent and stent delivery device |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9005270B2 (en) | 2012-03-27 | 2015-04-14 | Medtronic Vascular, Inc. | High metal to vessel ratio stent and method |
US8911490B2 (en) | 2012-03-27 | 2014-12-16 | Medtronic Vascular, Inc. | Integrated mesh high metal to vessel ratio stent and method |
WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
US8968384B2 (en) | 2012-04-27 | 2015-03-03 | Medtronic Vascular, Inc. | Circumferentially constraining sutures for a stent-graft |
JP6411331B2 (en) | 2012-05-10 | 2018-10-24 | パルサー バスキュラー インコーポレイテッド | Aneurysm device with coil |
US20130310687A1 (en) | 2012-05-21 | 2013-11-21 | Terumo Clinical Supply Co., Ltd. | Blood vessel embolization method using balloon catheter and balloon catheter for blood vessel embolization method |
US20130338688A1 (en) | 2012-06-18 | 2013-12-19 | Tausif ur Rehman | Sensory vascular clip |
US20140018902A1 (en) | 2012-07-12 | 2014-01-16 | Makor Issues And Rights Ltd. | Tailor-made stent graft and procedure for minimally invasive aneurysm repair with novel tailor-made balloon, novel guidewire, and novel capsulated bioglue |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US20140025151A1 (en) | 2012-07-20 | 2014-01-23 | Bulang Gao | Retrievable stent for intracranial aneurysms |
US10159489B2 (en) | 2012-07-30 | 2018-12-25 | Cook Medical Technologies Llc | Systems and methods for delivering multiple embolization coils |
US9277905B2 (en) | 2012-08-02 | 2016-03-08 | W. L. Gore & Associates, Inc. | Space-filling device |
EP2900306B1 (en) | 2012-09-27 | 2016-07-06 | Stryker Corporation | Method of forming a variably reinforced elongate medical device |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9186267B2 (en) | 2012-10-31 | 2015-11-17 | Covidien Lp | Wing bifurcation reconstruction device |
US20140128901A1 (en) | 2012-11-05 | 2014-05-08 | Kevin Kang | Implant for aneurysm treatment |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US20140130965A1 (en) | 2012-11-12 | 2014-05-15 | Medtronic Vascular, Inc. | Method of Manufacturing a Stent-Graft Prosthesis With Two Layers of Expanded Polytetrafluoroethylene |
KR102309795B1 (en) | 2012-11-13 | 2021-10-08 | 코비디엔 엘피 | Occlusive devices |
US8597323B1 (en) | 2012-11-16 | 2013-12-03 | Sequent Medical, Inc. | Delivery and detachment systems and methods for vascular implants |
US20140180377A1 (en) | 2012-12-20 | 2014-06-26 | Penumbra, Inc. | Aneurysm occlusion system and method |
US20140180387A1 (en) | 2012-12-21 | 2014-06-26 | Stryker Nv Operations Limited | Stent delivery system |
US10219924B2 (en) | 2012-12-26 | 2019-03-05 | Stryker Corporation | Multilayer stent |
WO2014110231A2 (en) | 2013-01-10 | 2014-07-17 | Trivascular, Inc. | Sac liner for aneurysm repair |
US10342546B2 (en) | 2013-01-14 | 2019-07-09 | Microvention, Inc. | Occlusive device |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US20140214071A1 (en) | 2013-01-28 | 2014-07-31 | Neurodynamics, Llc. | Embolic coil delivery system and method of using same |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US9498360B2 (en) | 2013-03-15 | 2016-11-22 | Stryker Corporation | Stent and method of use |
US8690907B1 (en) | 2013-03-15 | 2014-04-08 | Insera Therapeutics, Inc. | Vascular treatment methods |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
US9566071B2 (en) | 2013-04-11 | 2017-02-14 | Blockade Medical, LLC | Systems and devices for cerebral aneurysm repair |
-
2014
- 2014-12-07 US US14/562,725 patent/US9358140B1/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160220396A1 (en) * | 2011-09-09 | 2016-08-04 | Isis Innovation Limited | Stent and method of inserting a stent into a delivery catheter |
US10383749B2 (en) * | 2011-09-09 | 2019-08-20 | Oxford University Innovation Limited | Stent and method of inserting a stent into a delivery catheter |
US20150216684A1 (en) * | 2012-08-17 | 2015-08-06 | The Regents Of The University Of California | Dual rotational stent apparatus and method for endovascular treatment of aneurysms |
US9763812B2 (en) * | 2012-08-17 | 2017-09-19 | The Regents Of The University Of California | Dual rotational stent apparatus and method for endovascular treatment of aneurysms |
EP4138741A4 (en) * | 2020-04-20 | 2023-12-27 | Exovitra LLC | Methods and systems for treatment of aneurysms |
Also Published As
Publication number | Publication date |
---|---|
US9358140B1 (en) | 2016-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100131002A1 (en) | Stent with a net layer to embolize and aneurysm | |
US9358140B1 (en) | Stent with outer member to embolize an aneurysm | |
US8974487B2 (en) | Aneurysm occlusion device | |
CN106456182B (en) | Vascular occlusion device | |
JP4472525B2 (en) | Embolizer for vascular lesions | |
US10028747B2 (en) | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm | |
US8425548B2 (en) | Occluding member expansion and then stent expansion for aneurysm treatment | |
JP4324103B2 (en) | Stretch resistant treatment device | |
US10028745B2 (en) | Advanced endovascular clip and method of using same | |
US6511468B1 (en) | Device and method for controlling injection of liquid embolic composition | |
US20080045995A1 (en) | Aneurysm buttress arrangement | |
US20160206321A1 (en) | Aneurysm Occlusion Device with Sequence of Shape-Changing Embolic Members | |
US20160120551A1 (en) | Devices and Methods for Occluding a Cerebral Aneurysm | |
US20040172056A1 (en) | Bifurcated aneurysm buttress arrangement | |
US20190365472A1 (en) | Using 3D Imaging and 3D Printing to Occlude a Cerebral Aneurysm | |
JP2001286478A (en) | Aneurysm embolization device inserted in blood vessel | |
US11471163B2 (en) | Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies | |
CN114554979A (en) | Mesh occluder for improving herniation | |
US20150238195A1 (en) | Methods and systems for performing intralumenal procedures | |
US20210307760A1 (en) | Intrasacular Aneurysm Occlusion Device with a Flexible Net or Mesh and Polymer Longitudinal Embolic Members | |
US20130046326A1 (en) | Methods and systems for performing intralumenal procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: ANEUCLOSE LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JANJUA, MUHAMMAD TARIQ;REEL/FRAME:042258/0642 Effective date: 20170405 Owner name: ANEUCLOSE LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CONNOR, ROBERT A.;REEL/FRAME:042258/0581 Effective date: 20170405 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |